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 INTRODUCTION  
 
Siddha system of medicine is the most primitive medical system. This system 
was formulated and established about more than 5000 years back by the eminent 
powers called Siddhars and hence the name Siddha Medicine. The medicines were 
prepared by the various research work done by the Siddhars on herbs, minerals and 
animals. The father of Siddha Medicine is the primordial Guru, Agasthiar. There are 
also 18 prime Siddhars who are the followers of the primordial Guru, contributed their 
valuable knowledge and experiences in this field. 
Siddha medical system doesn‟t consider treatment and prevention separately. 
The main aim of this system is prevention of disease, as it is well said that “Prevention 
is better than cure” 
According to theory of Siddhars, human body is composed of Panchaboothas. 
The universe is composed of the same. Human body is microsmic and the Universe is 
macrosmic of the same. 
 As per siddha aspect, the physiological function of the human body is 
maintained by three humors called as vatham, pitham and kabam. The normal 
proportion of naadi is 1:1/2:1/4 respectively, any change in this proportion leads to 
many diseases. 
 Food plays vital role in the rhythmic run of three uyirthathus. 
 Our body doesn‟t requires medicine, if the food is taken on complete digestion. 
One of the disease occurred by irregular diet is Kalladaippu. 
Siddhars classified 4,448 types of disease. Within that kalladaippu is one of the 
disease commonly affecting men than women.
1 
Even though many siddhars explain about diseases, Yugi in his “YUGI 
VAIDHYA CHINTHAMANI 800” elaborately said the aetiology, pathology, 
classification, clinical features, and prognosis of kalladaippu. The diseases of urinary 
system are divided into two types, They are, 
         
            “                
                ” 
                                                                                                       INTRODUCTION 
 
Karpoora silasathu parpam for Kalladaippu Page 2 
 
The kalladaippu comes under the classification of “           
    ” which  produces low urine output and forms urinary calculi , due to various 
aetiological factors. 
In Greek “ouron” means „urine‟, “oros” means „flow‟, “Lithos” means „Stone‟, 
from which the term Urolithiosis came. 
Urolithiasis or Nephrolithiasis is formation of urinary calculi at any level of the 
Urinary tract. It is characterized by acute loin pain radiating to groin, and it consists of 
aggregates of crystals containing small amount of proteins and glycoprotein. Though 
various kinds of stone have been identified, calcium stones are the most common in 
human as well as rats
2 
Urinary  stone  disease  is  a  common  disorder  estimated  to  occur  in 
approximately 12%  of  the  world  population,  with  a  recurrence  rate  of  70‐81%  
in  males  and  47‐ 60% in females 3.  
The peak incidence is observed in 2
nd
 and 3
rd
 decades of life. 
According to Siddha system of medicine Kalladaippu occurs due to increase of 
Pitha. 
Now a days, the management of urolithiasis with open renal surgery is unusual 
and rarely used , since the introduction of extracorporeal shock wave lithotripsy 
,which is a standard procedure to remove kidney stones. However it may leave 
persistent stone fragments and cause acute renal injury, a decrease in renal function 
and an increase in stone recurrence
[4-6]
. The procedure is not widely available and very 
costly to the people in developing countries.  
In addition, the standard drugs used to prevent such lithiasis are not effective 
consistently in all patients, and many of them have adverse effects that compromise 
their long term use. Hence, the search for anti-lithiatic drugs from natural sources has 
gained more interest compared to earlier as shown in a recent study
[7]
.) 
On this basis, after accurate diagnosis Kalladaippu, Karpoora Silasathu Parpam 
is selected for clinical study to prove the efficacy of drugs in this disease. 
I preferred to select kalladaippu (urolithiasis) as dissertation topic because the 
prevalence is increasing day by day and many people prefer herbal medicines to 
remove stones rather than undergoing a painful surgery. Even the patients who were 
recommended for surgery have also been treated well using herbal medicines with 
satisfactory results.  
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So, I have chosen Kalladaippu (Urolithiasis) as dissertation topic to find out a 
complete cure without surgery. For this, I  have selected Karpoora Silasathu Parpam  
to study its effect on Kalladaippu both pharmacologically and clinically. 
This study is to look into various factors in the evolution of Kalladaippu and 
protocol of management with Karpoora Silasathu Parpam. 
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AIM AND OBJECTIVES 
AIM: 
 The aim of my dissertation work is to evaluate the efficacy of the siddha drug 
Karpoora Silasathu Parpam both clinically and experimentally in the treatment of 
kalladaippu. 
OBJECTIVES: 
 To collect the authorial measures and literature reviews of Kalladaippu 
noi in ancient siddha and modern literatures. 
 To have an idea of the incidence of the disease with regard to age, sex, 
occupation, socio economic status, food, climatic conditions and 
precipitating factors etc. 
 To expose the efficacy of Siddhar’s diagnostic principles. 
 To evaluate 
 Toxicological screening 
 Acute 
 Sub - acute 
 Pharmacological screening 
 Anti-Lithiatic activity 
 To utilize the possible methods to confirm the diagnosis and prognosis. 
 To have clinical trial on patients with Kalladaippu noi with selected 
siddha medicine. 
 Karpoora Silasathu Parpam 
 To find out the statistical analysis of clinical study 
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REVIEW OF LITERATURE 
SIDDHA  ASPECT  
Theran karisal says, 
 The diseases of the urinary system are divided into two types. They are  
“                
                       ”8 
The disease kalladaippu comes under the classification of “Neerinai Arukkal 
Noi”. In siddha system of medicine, the disease kalladaippu is mentioned by Yugi 
Munivar in Yugi Vaidhya Chinthamani 800. 
“                                  
                                  
                               ”9 
KALLADAIPPU NOI
VERUPEYAR (SYNONYMS) 
 Achmari 
IYAL (DEFINITION) 
 Sudden obstruction in the flow of urine, pain at the tip of the penis in males 
and clitoris in females, burning micturition, loin to groin pain, passing of small sand 
like stones along with urine are the cardinal features of this disease. 
10
 
Dehydration occurs due to overheat of the body. It leads to solid or crystalline 
aggregation from the dietary minerals in the kidney. The formed stone cannot expelled 
by kidnys leads to this diseased condition.
11
                                          
 Large concretions of stone in the bladder or kidney are known as calculus or gravel. 
 It is attended with difficulty in passing urine.
12
 Sudden obstruction to the flow of 
urine, pain at the tip of the penis in males and clitoris in females, burning micturition, 
pain in loin to groin region.
13
 
                                                        REVIEW OF LITERATURE 
 
Karpoora silasathu parpam for Kalladaippu Page 6 
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                                   ” 15 
 
If a stone present in the bladder, there will be frequency of Micturition.when 
the stone descends to urethra there will be obstruction of urine flow. It is cured 
through catheterization.
  NOI VARUM VAZHI (AETIOLOGY) 
 
“                              
                           
                            
                           
                             
                            
“                        
                         ” 
 
                                   
                                 
                         
                            
                          
                             
                           
                               .”16 
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     The urine constituents will easily deposit on the urinary tract and form the 
stone. At that time by vitiation of vatham and pitham these small stone becomes larger 
in size and block the urinary passage. The semen will stagnate for a long time in the 
urinary tract, so it will obstruct the urine flow Urinary stone are also formed due to the 
drinking of contaminated hard water, taking of food mixed with sand and small stones 
consuming of contaminated food articles, food containing more carbohydrates, 
unhealthy food habits
.
 
 
A urinary disease occasionally developed in the urinary bladder which is 
known as vesical calculus. It is said to be due to the deranged vayu encircling or 
prevailing in the region of the abdomen arising from any of the following causes. 
1) Suppression of seminal discharge during sexual intercourse. 
2) Retention of semen in the spermatic region in involuntary discharge 
during nocturnal emissions due to excessive heat in the body. 
           The calculus are stone which is formed in the bladder may vary in size from 
that of the particles of sand or mustard upto things as large as green gram or Bengal 
gram and sometimes attains the size of a hen’s egg even and block the passage of 
urine. It is accompanied by pain and difficulty in passing urine.
 17
 
                                                                               
                    “                  
                              
                
                   
                    
                  
                 
                 ”18 
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POTHU KURIGUNANGAL (Clinical features) 
 Gradual or sudden obstruction of the urine flow. 
 Unbearable pain in the penis 
 Excruciating pain and swelling is experienced at the tip of penis if the calculus 
attempts to expel. 
 Colicky pain radiating from loin to groin lower abdomen and urethra if the 
calculus is irregular with sharp projection.  
 Burning and scanty micturition and  Haematuria.19 
CLASSIFICATION 
 Classification according to yugimamunivar, 
“                           
                          
                        
                              
                          
                          
                        
                            ” 20          
According to Yugi vaidhya chinthamani, kalladaippu is classified into four 
types.
1) Vadha kalladaippu 
2) Piththa kalladaippu 
3) Silethuma kalladaippu 
4) Thondha kalladaippu 
       1)  Vadha kalladaippu: 
“                          
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                              .”20 
Acute pricking pain in the lower abdomen, scanty Micturition, obstruction to the flow 
of urine, pain in the penis, abdominal discomfort, and albuminuria will be present with 
mucous discharge and black coloured stone will be expelled. 
2)Piththa kalladaippu: 
“                        
                                 
                              
                             
                            
                               
                          
                            .”
Obstruction of urine flow, pricking pain and burning sensation in external 
meatus, expulsion of blood coloured stones. 
3)Silethuma kalladaippu: 
“                         
                             
                     
                              
                        
                                 
                         
                              ”21 
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Pricking pain in umbilicus, pain in the joints of hands and legs, expulsion of 
white coloured stone in urine, excessive sweating. 
5) Thondha kalladaippu: 
“                         
                             
                         
                                       
                        
                                
                           
                                 ”22 
Severe pain in urethra, Dysuria, Oliguria, handful of small sand like stones will expel 
with severe pain.
 
     
 
According to Dhanvanthri, 
“                                  
                                  
                               
                               ”23 
Achmari is classified into four types, 
           1) Kallerippan 
2)Silethuma achmari 
3)Piththa achmari 
4)Sukkilachmari 
1) Kallerippan gunam: 
“                                
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                                       .”23 
Formations of stones in the urinary tract, oliguria, pricking pain around the 
umbilicus, fever, anorexia are the symptoms of this type. 
2) Silethuma achmari gunam: 
                                        
                                          
                                            
                                 ” 24 
Oliguria due to obstruction of stone in urethral orifice, stones can be expelled out into 
pieces
. 
 
 
3) Piththa achmari gunam: 
“                                     
                                   
      
                                   
                                .” 24 
Burning micturition in urethral orifice, formations of stones, severe pain are 
the symptoms 
    4)Sukkilachmari gunam:
 
“                                 
                              
                                   
                                   .”25 
Stagnation of semen leads to the formation of stones, oliguria, and expulsion of 
small sand like stones. It is fatal
.
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 SAATHIYAM, ASAATHIYAM (PROGNOSIS) 
As per yugi, 
 Vatha kalladaippu, piththa kalladaippu, silethuma kalladaippu are curable. 
Thondha kalladaippu is fatal. 
“                            
                       
                     
                       
                       
                          
                          
                          .”26 
MUKKUTRA VAERUPADUGAL (PATHOGENESIS): 
 Disease occurs due to the derangement in 
 Uyir thathukkal 
 Udal thathukkal 
 Kalamarupadu (seasonal changes) 
 Thinai (living lands) and 
 Udal vanmai. 
Mukkutra iyal: 
 The function of the three uyir thathus: 
a) Vali – Kattru + Veli 
b) Azhal – Thee  
c) Iyyam – Neer + Mann 
The alteration of three thathu in their reaction to extrinsic or intrinsic factors 
results in disharmony. This altered harmony and balance variation of the three thathus 
results in disease. Their natural ratio (1:1/2:1/4) to each other is discerned by the 
physician at the wrist and each nadi is individually assessed for its strength, speed and 
regularity. 
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VATHAM 
 The term vatham denotes vayu, dryness, pain and flatulence. Based on 
functions and locations it is classified into ten types. They are tabulated below. 
S.No Vatham General Features Changes in 
Kalladaippu 
1 Piranan 
(Uyirkkaal) 
Responsible for respiration and it is 
necessary for proper digestion. 
Normal 
2 Abanan 
(Keel nokkukkaal) 
Responsible for all the downward forces 
such as voiding of urine, stools, semen, 
menstrual flow. 
Affected 
    (scanty 
Micturition) 
3 Viyanan 
(Paravukaal) 
Dwells in the skin and is concerned with 
the sense of touch, extension and flexion 
of the parts of the body and distribution 
of the nutrients to various parts of the 
body. 
Normal 
4 Uthanan  
(Melnokkukaal) 
Responsible for all kinds of upward 
motion such as nausea, vomiting etc., 
Affected 
    (Nausea, 
vomiting) 
5 Samanan 
(Nadukkaal) 
Considered essential for proper digestion, 
assimilation and carries the digested 
nutrients to each and every organ. 
Affected 
6 Nagan Helps in opening and closing of eyelids. Normal 
7 Koorman Responsible for vision, lacrimation and 
yawning. 
Normal 
8 Kirugaran Induces appetite, salivation, all secretions 
in the body including nasal secretion and 
sneezing. 
Normal 
9 Thevathaththan Induces and stimulates a person to 
become alert, get anger, to quarrel, to 
sleep etc., 
Normal 
10 Dhananjeyan Resides in the cranium and produces 
bloating of the body after death. This 
leaves from the body after 3 days of 
death, forming a way through the skull
27
 
Normal 
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PITHAM 
 It is the thermal life force of the body. It is sub divided into five types. They 
are 
 
S.No 
 
Pitham 
 
General Features 
 
Changes in 
Kalladaippu 
1 Anarpitham Peps up the appetite and aids in digestion. Normal 
2 Ranjagapitham Responsible for the colour and contents of 
blood. 
Normal 
3 Saathagapitham Controls the whole body and is held 
responsible for fulfilling a purpose. 
Affected 
(Dysuria, 
Oliguria) 
4 Pirasagapitham Dwells in the skin and concerned with the 
shine, glow, texture and its complexion. 
Normal 
5 Alosagapitham Responsible for the perception of vision.
28
 Normal 
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KABHAM 
 It is responsible for the stream line functions of the body and maintains body’s 
defence mechanism intact. It is again classified into 5 types. 
 
S.No 
 
KABHAM 
 
GENERAL FEATURES 
CHANGES IN 
KALLADAIPPU 
1 Avalambagam Lies in the respiratory organs, 
exercises authority over other kabhas 
and control the heart and circulatory 
system. 
Normal 
2 Kilethagam Found in stomach as it seat, moistens 
the food, softens and helps to be 
digested. 
Normal 
3 Pothagam Responsible for the perception of 
taste 
Normal 
4 Tharpagam Presents in the head and is 
responsible for the coolness of the 
eyes, sometimes may be referred to 
as cerebrospinal fluid. 
Normal 
5 Santhigam Necessary for the lubrication and the 
free movements of joints
.29
 
Normal 
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PARUVAKALAM 
S.No Perum pozhuthugal Mukkutra marupaadugal 
1 Kaar kaalam 
(Aavani & Purattasi) 
Mid August to Mid October 
VATHAM - Vaetrunilai valarchi 
PITHAM – Thannilai valarchi   
2 Koothir kaalam 
(Iypasi & Karthigai) 
Mid October to Mid December  
VATHAM – Thannilai adaidhal 
PITHAM - Vaetrunilai valarchi 
3 Munpani kaalam 
(Margazhi & Thai) 
Mid December to Mid February  
PITHAM – Thannilai adaidhal 
4 Pinpani kaalam 
(Masi & Panguni) 
Mid February to Mid June  
KABHAM – Thannilai valarchi 
5 Elavenir kaalam 
(Chithirai & Vaikaasi) 
Mid April to Mid June  
KABHAM – Vaetrunilai valarchi 
6 Mudhuvenir kaalam 
(Aani & Aadi) 
Mid June to Mid August  
VATHAM – Thannilai valarchi 
KABHAM – Thannilai adaidhal30 
 
 
THINAI (LAND) 
 Siddhars classified the lands into five types. They are  
1. Kurunji – Mountain range 
2. Mullai – Pastoral area of the forest 
3. Marudham – The fertile river bed 
4. Neidhal – The coastal region 
5. Paalai – Arid desert 
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Kabha diseases will occur in Kurinji land. Pitha diseases occur in Mullai land. 
Vadha diseases occur in Neidhal land. Staying in Paalai land is not good to health. 
Marudham land is the fertile area where no disease occurs. So, Marudham land is the 
best one to stay.The winter season gives good health to the man, early summer and 
later rainy gives moderate health. Whereas early rainy and later summer are more 
prone to diseases, that’s why siddhars called it as Aanaga kaalam. 31 
RELATION BETWEEN MUKKUTRAM, KAALANGAL AND THINAIGAL 
 
 
Mukkutram 
Paruvakaalam (Seasons)  
 
Thinai 
Thannilai 
valarchi 
(Accumulation) 
Vaetrunilai 
valarchi 
(Aggravation) 
Thannilai 
adaidhal 
(Alleviation) 
VATHAM Mudhuvenil 
kaalam 
Kaar kaalam Koothir kaalam Vatha disease is 
more prevalent in 
Neidhal land  
PITHAM Kaar kaalam Koothir kaalam Munpani kaalam Pitha disease is 
more prevalent in 
Mullai land 
KABHAM Pinpani kaalam Elavenil kaalam Mudhuvenil 
kaalam
32 
Kabha disease is 
more prevalent in 
Kurunji land
33 
 
UDAL VANMAI (IMMUNITY) 
 Siddhars classify udal vanmai into three types. They are 
1. Iyarkai vanmai 
2. Kala vanmai 
3. Seyarkai vanmai 
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UDAL KATTUGAL 
S.No Udal kattugal General Features Changes in 
Kalladaippu 
1 Saaram 
 (Digestive essence) 
Responsible for the growth and 
development. It keeps the 
individual in good temperament 
and it enriches the body. 
Affected due 
to pain 
2 Senneer (Blood) Responsible for the color of the 
blood and for the intellect, 
nourishment, strength of the 
body. 
Normal 
3 Oon (Muscle) Gives lookable contour to the 
body as needed for the physical 
activity. It feed the fat next day 
and gives a sort of plumpness to 
the body. 
Normal 
4 Kozhuppu (Fat) Lubricates the organs to facilitate 
frictionless functions. 
Normal 
5 Enbu (Bones) Supports and protects the vital 
organs, gives the definite 
structure of the body and 
responsible for the posture and 
movements of the body. 
Normal 
6 Moolai (Bone marrow) Nourishes the bone marrow and 
brain which is the centre that 
controls other system of body. 
Normal 
7 Sukkilam/Suronitham  Responsible for reproduction.
34
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PINIYARI MURAIMAI (DIAGNOSIS) 
   Four steps are followed in diagnosing the disease. They are 
1. Poriyaal aridhal 
2. Pulanal therdhal 
3. Vinaadhal 
4. Envagai thervugal 
PORIYAAL ARIDHAL: 
 In this, the physician should carefully observe the changes that occur in the 
five sensory organs (porigal) of the patient. 
PULANAL THERDHAL: 
 The physician carefully applies his five senses of perception, smell, taste, 
vision, touch and sound to understand the condition of the patient. 
VINAADHAL: 
 The physician should interrogate about the patients name, age, occupation, 
socio- economic status, food habits, history of past illness, history of present illness, 
family history, marital status, menstrual history and frequency of pain. 
ENVAGAI THERVUGAL: 
 “                       
                             .”35 
                 
Nowadays advanced diagnostic tools have been developed by modern bio 
medical scientists. But siddhars have given eight diagnostic methodological tools. 
They are called as Envagai thervu.
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Eight fold system of clinical assessments: 
 Siddhars have given eight diagnostic methodological tools. They are 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram36 
GENERAL FINDINGS: 
NAADI: 
 Naadi is responsible for the existence of life, can be felt one inch below the 
wrist on the radial side by means of palpation with tips of index, middle and ring 
finger, corresponding to vatham, pitham, kabham. 
 Three humours Vatham, Pitham, and Kabham are in the ratio 1:1/2:1/4 
normally. Derangement in these ratio leads to various disease conditions. 
Naadi nadai in kalladaippu 
 When the vatham add with mandham it produces the kalladaippu disease. 
“                                    
                                   
                                   
                              .”37 
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SPARISAM: 
 By sparisam, the temperature of skin (thatpam- cold or veppam – heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal growth of 
organs and tenderness can be felt. 
 In Kalladaippu, patient feels tenderness over the lower abdomen, renal angle 
and lumbar region. Also patient’s temperature is increased in lower abdomen, 
sweating all over the body at the time of colic.  
NAA: 
 Signs and symptoms in the tongue are noted here. Colour, salivary secretion, 
ulcers, coating, inflammation, taste changes, deviation and its nature are generally 
noted. 
 In kalladaippu, the naa is not affected. 
NIRAM: 
 The colour of the skin is noted here. 
 In kalladaippu, the Niram may be affected in sukkila achmari. 
 
MOZHI: 
 Character of the speech is noted, mainly uraththa oli (high pitched), thazhndha 
oli (low pitched), or resembles the sound of any instrument. 
 In kalladaippu, the mozhi will be affected to the patients who have severe pain 
leading to the thazhndha oli. 
 
VIZHI: 
 Character of the eye is noted. Colour, warm, burning sensation, irritation, 
visual perception are generally noted. 
 In kalladaippu, the vizhi may be affected. Redness due to renal colic pain. 
 
MALAM: 
 The stools are examined for quantity, hardening (malakattu), loose motion 
(bedhi), colour and smell. 
 In kalladaippu, the malam will be affected due to either constipation or 
diarrhoea. 
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MOOTHIRAM 
a) NEERKURI (Urine examination) 
 Urine examination is good diagnostic method compare to naadi and 
other Envagai thervugal. Theraiyar mention it as. 
 
“                           
                          
                      
                      
                          
                        .”38 
The early morning urine sample is collected and sample should be examined 
within one and hour hours.
 
SIRUNEERIN POTHU GUNAM: 
  “                             
                                  .”38 
        The urine is examined for its Niram (colour), Eadai (Specific gravity), Nurai 
(Froth), Natram (Smell), Enjal (Deposits). In kalladaippu, the moothiram is affected 
due to scanty Micturition. 
NIRAM (COLOUR) 
     “                           
                                       .”39 
1. Yellow 
2. Red 
3. Green 
4. Black 
5. White  
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KALLADAIPPU NEERIN GUNAM (COLOUR INDICATING URINARY 
STONES) 
  
The urine colour would look like flesh washing water; this is indicated in 
kidney diseases. This is mentioned as 
  
“                           
                          
                             
                   .”40 
EADAI (SPECIFIC GRAVITY) 
 Urine, not thick is considerably healthy. This is mentioned as 
“                           
                            .”41 
 
NURAI (FROTH) 
 Urine may be frothy in nature, if it is reduced in vali, azhal and ayyam are said 
to be deranged. This is mentioned as 
 
“                        
                        
                     .”42 
  
NAATRAM (SMELL)
 Foul odour with pyuria is observed in patients with urinary lithiasis associated 
with urinary tract infection and ulcer. This is mentioned as 
“                            
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                      .”41 
 
ENJAL (DEPOSITS) 
 If urine excretion look like curd water white colour and sand like deposits in 
urine indicate stones in kidney. This is mentioned as 
 
“                                    
                                
                                 
                                .”43 
NEIKURI
 
 The early morning urine of the patient is analyzed by dropping a drop of 
gingely oil on the surface of the urine sample. The accumulation, formations, changes, 
and dispersal under the sunlight without any external disturbances of the urine sample 
can be noted. 
The urine kept on the kidney tray in sun light, on non wind condition, should 
be by dropping a drop of gin oil gently with rod. If oil spread like snake, it indicates 
vali neer; a ring indicates azhal neer and float like a pearl indicates iyya neer and sinks 
in urine indicates mukkutram. 
                       “                   
                        
                          ”.44 
 Vatha neer – The oil spreads like snake 
 Pitha neer – The oil spreads like ring 
 Kabha neer – The oil spreads like pearl 
 If the oil spreads gradually, it indicates good prognosis45 
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 If the oil spreads fast or gets mixed completely with urine or sinks in urine, it 
suggests bad prognosis.
46
 
    Since kalladaippu is due to the derangement of vatham and pitham, the Neikuri will 
be vatha or pitha neer.   
 
  MARUTHUVAM (LINE OF TREATMENT) 
 The entire siddha system of medicine consists of three great subdivisions 
namely, 
1) Noyillaneri (preventive) – Kaappu 
2) Noineekuneri (curative methods) – Neekkam 
3) Uramaakkumurai (strengthening methods) - Niraippu . 
 
            Noyillaneri is the special approach of the siddha system where regular dietary 
habits, early rising, physical and mental discipilinaries are all emphasized. Prevention 
can mostly save our body and soul, but modernization results in alteration of good 
health, leads to disease.  
 
Siddha system is playing major role in treating and preventing many chronic 
diseases. Likewise, herbal medicines have several phyto chemicals which exert their 
beneficial effect on urolithiasis by multiple mechanisms like, 
 Diuretic activity 
 Crystallization inhibiting activity 
 Anti-Litiatic activity 
 Antimicrobial activity 
 Analgesic and anti inflammatory activity 
 Improving renal function 
 Regulates oxalate, calcium mechanisms. 
 
          The main object of treatment is to bring down the deranged mukkutrams to 
natural equilibrium by giving purgatives, which cure derangement of vatham; this is 
one of the causes for kalladaippu. 
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 In Siddha system, treatment is not only removable of disease but also the 
prevention and improving the body condition after removal of disease. This is said as 
kappu, neekkam and niraippu. 
 
Fomentation: 
 An attack of renal colic may be aborted by the application of heat fomentation 
(hot water bottle or heater) to the lumbar region. Immediate treatment of loin pain or 
renal colic is bed rest. 
 
PREVENTION: 
 
1. For prophylactic purpose it is necessary to eliminate all hindrances to a free 
drainage of urine (constriction, adenoma of the prostrate etc) and to remove 
foci of infection from the teeth and tonsils. 
2. To prevent the formation of urate calculi, a diet of milk and vegetables and 
mineral water is prescribed. 
a. In the presence of oxalate calculi restrictions are imposed on foods rich 
in calcium (milk, raw eggs, potatoes) with total abstinence from 
chocolate, spinach gooseberries and carrots. 
3. A patient with phosphorus, carbonate stones is kept on a meat diet and much 
water to drink. 
 
ADVICE: 
1. Patients should drink large amount of water (2 - 3 lit/day) 
2. Patient should not suppress the excretion of urine and seminal fluid. 
3. Preparation containing Vit. D must be avoided. 
4. Regarding prevention Anubhava vaidhya deva ragasiyam states that one should 
not suppress the excretion of Moothiram (urine) and Sukkilam (Seminal fluid). 
 
NOI KANIPPU VIVADHAM (DIFFERENTIAL DIAGNOSIS) 
1) Neerkattu (Anuria) 
2) Neerchurukku (Oliguria) 
3) Chottu neer (Incontinence) 
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DO’S AND DONT’S: 
 
DO’S: 
1) Drink 2-3 litres of water per day. 
2) Dring tender coconut, barley water, lemon juice, raddish juice. 
3) The following vegetables can be taken in the diet 
Raddish  
Lady’s finger 
Plantain pith 
Mint leaves 
Bottle guard 
 
DONT’S: 
1) Avoid cabbage, cauliflower, and tomato seeds, mushroom. 
2) Avoid milk and its products. 
3) Avoid chicken, fish and other sea foods 
Avoid drinking fluoride containing water  
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MODERN ASPECT 
 
ANATOMY AND PHYSIOLOGY OF THE URINARY SYSTEM 
 
KIDNEYS 
 
 The kidneys are a pair of excretory organs situated on the posterior abdominal 
wall, one on each side of the vertebral column, behind the peritoneum. They remove 
waste products of metabolism and excess of water and salts from the blood, and 
maintain its pH. 
 
 
 
 
 
 
 
EXTERNAL FEATURES 
 Each kidney is bean shaped. It has upper and lower poles, medial and lateral 
borders, and anterior and posterior surfaces. 
TWO POLES OF THE KIDNEY 
 The upper pole is broad and is in close contact with the corresponding 
suprarenal gland. The lower pole is pointed. 
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TWO SURFACES 
 The anterior surface is said to be irregular and the posterior surface flat, but it 
is often difficult to recognize the anterior and posterior aspects of the kidney by 
looking at the surfaces. The proper way to do this is to examine the structures present 
in the hilum as described below. 
 
TWO BORDERS 
 The lateral border is convex. The medial border is concave. Its middle part 
shows a depression, the hilus or hilum. 
 
HILUM 
 The following structures are seen in the hilum from anterior to posterior side: 
1) The renal vein 2) the renal artery and 3) the renal pelvis, which is the expanded 
upper end of the ureter. Examination of these structures enables the anterior and 
posterior aspects of the kidney to be distinguished from each other. As the pelvis is 
continuous, inferiorly, with the ureter the superior and inferior poles of the kidney can 
also be distinguished by examing the hilum. So it is possible to determine the side to 
which a kidney belongs by examining the structures in the hilum. Commonly, one of 
the branches of the renal artery enters the hilus behind the renal pelvis, and a tributary 
of the renal vein may be found in the same plane. 
 
LOCATION 
 The kidneys occupy the Epigastric, hypochondriac, lumbar and umbilical 
regions. Vertically they extend from the upper border of twelfth thoracic vertebra to 
the centre of the body of the third lumbar vertebra. 
 The right kidney is slightly lower than the left, and the left kidney is a little 
nearer to the median plane than the right. 
  
SHAPE, SIZE, WEIGHT AND ORIENTATION 
 Each kidney is about 11cm long, 6 cm broad and 3 cm thick. The left kidney is 
a little longer and narrower than the right kidney. On an average the kidney weighs 
150 g in males and 135 g in females. The kidneys are reddish brown in colour. 
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 The long axis of the kidney is directed downwards and laterally, so that the 
upper poles are nearer to the median plane than the lower poles. The transverse axis is 
directed laterally and backwards. 
 
CAPSULES OR COVERINGS OF KIDNEY 
 
1. The fibrous capsule: This is a thin membrane which closely invests the kidney 
and lines the renal sinus.  
2. Perirenal or perinephric fat: This is a layer of adipose tissue lying outside 
the fibrous capsule. It is thickest at the borders of the kidney and fills up the 
extra space in the renal sinus. 
3. Renal fascia: This is a fibroareolar sheath which surrounds the kidney and the 
perirenal fat called as the fascia of Gerota. It consists of an anterior layer or 
fascia of Toldt and a posterior layer or fascia of Zuckerkandl. 
4. Pararenal or paranephric body (fat): It consists of a variable amount of fat 
lying outside the renal fascia. It is more abundant posteriorly and towards the 
lower pole of the kidney. It fills up the paravertebral gutter and forms a 
cushion for the kidney. 
 
Naked eye examination of a coronal section of the kidney shows: a) an outer, 
reddish brown cortex; b) an inner, pale medulla; c) a space, the renal sinus. 
 
The renal medulla is made up of about 10 conical masses, called the renal 
pyramids. Their apices form the renal papillae which indent the minor calices. 
 The renal cortex is divisible into two parts: a) cortical arches or cortical 
lobules, which form caps over the bases of the pyramids; and b) renal columns, which 
dip in between the pyramids. Each pyramid along with the overlying cortical arch 
forms a lobe of the kidney. 
 The renal sinus is a space that extends into the kidney from the hilus. It 
contains a) branches of the renal artery; b) tributaries of the renal vein; and c) the renal 
pelvis. The pelvis divides into 2 to 3 major calices, and these in their turn divide into 7 
to 13 minor calices. Each minor calyx ends in an expansion which is indented by one 
or three renal papillae. 
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 Histologically, each kidney is composed of one to three million uriniferous 
tubules. Each tbule consists of two parts which are embryologically distinct from each 
other. These are as follows. 
A) The secretory part, called the nephron, which elaborates urine. Nephron is the 
functional unit of kidney and comprises the renal corpuscle or Malphigian 
corpuscle and the renal tubule. 
B) The collecting tubule begins as a junctional tubule from the distal convoluted 
tubule. Many tubules unite together to form the ducts of Bellini which open 
into minor calices through the renal papillae. 
C) Juxtaglomerular apparatus is formed at the vascular pole of glomerulus 
which is intimately related to its own ascending limb of the Henle’s loop near 
the distal convoluted tubule. 
 
BLOOD SUPPLY 
 
 Usually there is one renal artery on each side, arising from the abdominal 
aorta. Accessory renal arteries are present in 30% of individuals; they arise 
commonly from the aorta, run parallel to the renal artery, and enter the kidney 
either at the hilus or at one of its poles. 
 At or near the hilus the renal artery divides into anterior and posterior 
divisions. Further branching of these divisions gives rise to segmental arteries each 
of which  
supplies one vascular segment. Five such segments are described. These are apical, 
upper, middle, lower and posterior. The segmental arteries are end arteries, so that 
the vascular segments are independent units. 
 
VENOUS DRAINAGE 
 The venous end of the peritubular capillary plexus gives rise to interlobular 
veins which run along the corresponding arteries. The interlobular veins drain into 
the arcuate veins, which in their turn open into the interlobar veins. These emerge 
at the renal sinus and join to form the renal vein which drains into the inferior vena 
cava. 
 The venous end of the capillary plexus along the vasa recta gives rise to veins 
which drain into the arcuate veins. 
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LYMPHATIC DRAINAGE 
 The lymphatics of the kidney drain into the lateral aortic nodes located at the 
level of origin of the renal arteries. 
 
 
 
 
NERVE SUPPLY 
The kidney is supplied by the renal plexus, an offshoot of the celiac plexus. It 
contains sympathetic (T10 – L1) fibres which are chiefly vasomotor. The afferent 
nerves of the kidney belong to segments T10 to T12. 
FUNCTIONS OF KIDNEYS 
Kidneys perform vital functions. By excreting urine, kidneys play principal role in 
the maintenance of internal environment. In addition, kidneys perform many other 
functions as described below. 
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1. ROLE OF HOMEOSTASIS 
The primary function of kidneys is homeostasis. It is accomplished by the 
formation of urine. Kidneys are not only the excretory organs, but are also the 
regulatory organs because their major role is in homeostasis. During the formation 
of urine, kidneys regulate various activities in the body, which are concerned with 
homeostasis. 
 
Excretion of waste products: Removal of wastes help in homeostasis. 
Kidneys excrete the unwanted waste products which are formed during metabolic 
activities. 
a. Urea – end product of amino acid metabolism 
b. Uric acid – end product of nucleic acid metabolism 
c. Creatinine – end product of metabolism in muscles 
d. Bilirubin – end product of hemoglobin degradation 
e. Products of metabolism of other substances. 
Kidneys also excrete harmful foreign chemical substances like: 
a. Toxins 
b. Drugs 
c. Heavy metals 
d. Pesticides etc., 
 
Maintenance of water balance: Kidneys maintain the water balance in the body 
by conserving water when it is decreased and excreting water when it is excess in 
the body. This is a very important process for homeostasis. 
 
Maintenance of electrolyte balance: Maintenance of electrolyte balance, 
especially sodium is in relation to water balance. Kidneys retain sodium if the 
osmolarity of body water decreases and eliminate sodium when osmolarity 
increases. 
 
Maintenance of acid base balance: The pH of the blood and body fluids should 
be maintained within narrow range for healthy living. It is achieved by role of 
kidneys. Body is under constant threat to develop acidosis, because of production 
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of lot of acids during metabolic activities. However, it is prevented by kidneys, 
lungs and blood buffers, which eliminate these acids. Among these organs, kidneys 
play major role in preventing acidosis. In fact, kidneys are the only organs, which 
are capable of eliminating certain metabolic acids like sulfuric and phosphoric 
acids. 
 
2. HEMOPOIETIC FUNCTION 
Kidneys stimulate the production of erythrocytes by secreting erythropoietin. 
Erythropoietin is the important stimulating factor for erythropoiesis. Kidney also 
secretes another factor called thrombopoietin, which stimulates the production of 
thrombocytes. 
 
3. ENDOCRINE FUNCTION 
Kidneys secrete many hormonal substances in addition to erythropoietin and 
thrombopoietin. The hormones secreted by kidneys are: 
a. Erythropoietin 
b. Thrombopoietin 
c. Renin 
d. 1, 25 – Dihydroxycholecalciferol 
e. Prostaglandins 
 
4. REGULATION OF BLOOD PRESSURE 
Kidneys play an important role in the regulation of arterial blood pressure. 
Kidneys regulate arterial blood pressure by two ways: 
1. By regulating the volume of extracellular fluid 
2. Through renin – angiotensin mechanism 
 
5. REGULATION OF BLOOD CALCIUM LEVEL 
Kidneys play a role in the regulation of blood calcium level by activating 1, 25 
– dihydroxycholecalciferol into vitamin D. Vitamin D is necessary for the 
absorption of calcium from intestine
44
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MECHANISM OF URINE FORMATION 
 The process involve in urine formation are, 
1. Glomerular filtration 
2. Tubular reabsorption 
3. Tubular secretion 
 
GLOMERULAR FILTRATION 
 Glomerular filtrate is protein free plasma. Glomerular filtration is depends 
upon hydrostatic pressure of the afferent arterioles, glomerular capillary pressure and 
colloidal osmotic pressure. The glomerular filter contains all the substance present in 
the plasma except colloids. 
 Normal amount of urine excreted per day is about 1.5 litres. The glomerular 
filtrate is alkaline. It contains water, small quantities of urea, glucose, potassium, 
calcium, bicarbonates and uric acid. 
 
TUBULAR REABSORPTION 
 When the glomerular filtrate flows through the tubular portion of nephron, both 
quantitive and qualitative changes occur. Large quantity of water (more than 99%), 
electrolytes and other substances are reabsorbed by the tubular epithelial cells. The 
reabsorbed substances move into the interstitial fluid of renal medulla. And, from here, 
the substances move into the blood in peritubular capillaries. 
 Since the substances are taken back into the blood from the glomerular filtrate, 
the entire process is called tubular reabsorption. 
 
TUBULAR SECRETION 
 In addition to reabsorption from renal tubules, some substances are also 
secreted into the lumen from the peritubular capillaries through the tubular epithelial 
cells. It is known as tubular secretion or tubular excretion. 
  Thus, urine is formed in the nephron by the processes of glomerular filtration, 
selective reabsorption and tubular secretion
45
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URETERS 
The ureters are a pair of narrow, thick-walled muscular tubes which convey urine 
from the kidneys to the urinary bladder.  
They lie deep to the peritoneum, closely applied to the posterior abdominal wall in 
the upper part, and to the lateral pelvic wall in the lower part. 
 
DIMENSIONS 
Each ureter is about 25 cm (10 in.) long, of which the upper half (5 in.) lies in 
the abdomen, and the lower half (5 in.) in the pelvis. It measures about 3mm in 
diameter, but it is slightly constricted at three places. 
 
COURSE 
The ureter begins within the renal sinus as a funnel shaped dilatation, called the 
renal pelvis. The pelvis issues from the hilus of the kidney, descends along its median 
margin, or partly behind it. Gradually it narrows till at the lower end of the kidney it 
becomes the ureter proper. 
The ureter passes downwards and slightly medially on the psoas major muscle, and 
enters the pelvis by crossing in front of the termination of the common iliac artery. In 
the lesser or true pelvis the ureter at first runs downwards, and slightly backwards and 
laterally, following the anterior margin of the greater sciatic notch. Opposite the 
ischial spine it turns forwards and medially to reach the base of the urinary bladder. 
The ureter enters the bladder wall obliquely to open into it at the lateral angle of its 
trigone. 
 
CONSTRICTIONS 
The ureter is slightly constricted at three places: 1) at the pelviureteric junction; 
2) at the brim of the lesser pelvis; 3) at its passage through the bladder wall. The renal 
stones tend to get arrested at these places. 
 
BLOOD SUPPLY 
Upper part receives branches from renal artery, gonadal or colic vessels, 
middle part receives branches from aorta, the gonadal or iliac vessels, and pelvic part 
is supplied by branches from the vesical, middle rectal or uterine vessels. 
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NERVE SUPPLY 
The ureter is supplied by sympathetic from T10 – L1 segments and 
parasympathetic from S2 – S4 nerves. They reach the ureter though the renal, aortic 
and hypogastric plexuses. All the nerves appear to be sensory in function
46
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URINARY BLADDER 
The urinary bladder is a muscular reservoir of urine, which lies in the anterior 
part of the pelvic cavity. The detrusor muscle of urinary bladder is arranged in whorls 
and spirals and is adapted for mass contraction rather than peristalsis. 
 
SIZE, SHAPE AND POSITION 
The bladder varies in its size, shape and position according to the amount of 
urine it contains. When empty it lies entirely within the pelvis; but as it fills it expands 
and extends upwards into the abdominal cavity, reaching up to the umbilicus or even 
higher. 
 
EXTERNAL FEATURES 
An empty bladder is tetrahedral in shape and has: a) An apex, directed forwards; b) 
a base or fundus, directed backwards; c) a neck, which is the lowest and most fixed 
part of the bladder; d) three surfaces, superior and right and left inferolateral; and e) 
four borders, two lateral, one anterior and one posterior. 
A full bladder is ovoid in shape and has: a) An apex, directed upwards towards the 
umbilicus; b) a neck, directed downwards, and c) two surfaces, anterior and posterior. 
 
INTERNAL SPHINCTER OF THE BLADDER 
The bladder wall is made up of longitudinal and circular layers of smooth 
muscles and they are called detrusor muscle. In the trigone in addition to detrusor 
muscle, there is trigonal muscle of bell. There is no definite circular muscle fibre at the 
neck of the bladder stop at the level of neck. Longitudinal fibres from the posterior 
wall diverge to pass around the urethra on both sides. 
 
CAPACITY OF THE BLADDER 
The mean capacity of the bladder in an adult male is 220 ml, varying from 120 
to 320 ml. filling beyond 220 ml causes a desire to micturate, and the bladder is 
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usually emptied when filled to about 250 – 300 ml. filling upto 500 ml may be 
tolerated, but beyond this it becomes painful. Referred pain is felt in the lower part of 
the anterior abdominal wall, perineum and penis (T11 to L2; S2 – S4). 
 
BLOOD SUPPLY 
Superior vesicle arteries and inferior vesicle arteries supplies the bladder. In 
addition branches from obturator and inferior gluteal artery are supplied to the bladder. 
 
NERVE SUPPLY 
Sympathetic fibers arise from T11 – L2 segment. Parasympathetic fibres branches 
from S2 – S4. Somatic pudental nerve supplies the sphincter urethrae which is 
voluntary. 
 
URETHRA 
Urethra is a tubular passage extending from the neck of the bladder to the external 
urethral orifice. 
 The male urethra extends from the internal urethral orifice at the neck of 
urinary bladder to the external urethral orifice at the tip of the penis. It is about 20 
cm long in flaccid state of the penis; the long axis of urethra shows 2 curvatures 
and is therefore S shaped. In the erect state it becomes J shaped. 
It is divided into 3 parts 
1) Prostatic part                     : Passes through prostate (3 cm long) 
2) Membraneous part            : Surrounded by sphincter (2 cm long) 
3) Spongy part (Penile part)  : Passes through the bulb and carpus 
                                             spongiosum (15 cm long) 
48
 
 
SPHINCTER OF THE URETHRA 
 There are 2 sphincters, in relation with urethra internal and external. The 
internal sphincter made up of smooth muscle fibre and situated at the neck of the 
bladder is supplied by sympathetic nerves from lower thoracic segments and upper 
lumbar segments. 
 The external sphincter made of light striated muscle fibre surrounds the 
membraneous part of urethra; it is supplied by prineal branch of the pudental nerve (S2 
to S4). 
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BLOOD SUPPLY 
 Branches of internal pudental artery supplies urethra
49
.  
 
THE FEMALE URETHRA 
The female urethra is only 4 cm long and 6 mm in diameter. Developmentally, 
it corresponds to the upper part of the prostatic urethra of the male. 
 It begins at the internal urethral orifices roughly 5 cm behind the middle of the 
pubic symphysis. It runs downwards and forwards embedded in the anterior wall of 
the vagina, traverse the urogenital diaphragm and ends at the lateral urethral orifices in 
the vestibule. 
 The mucosa of the urethra is much folded and contains numerous mucous 
glands and lacunae which open into the urethra. The collections of mucous glands one 
on each side of the upper part of the urethra is called the paraurethral glands of skene. 
 The female urethra is dilatable
49
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                               RENAL CALCULI (UROLITHIASIS) 
                 
                 
 
        It refers to calculus formation at any level in the urinary tract but most arise in the 
kidney.calculi are common in the renal pelvis, calyces and collecting ducts of people 
in industrialized countries, and is the third most common disorder of the urinary tract
54
 
    
  Urolithiasis is a frequent clinical problem, affecting 5 to 10% of Americans in 
their lifetime. Males are affected more often than females and the peak age at onset is 
between20 and 30 years. Familial hereditary predisposition to stone formation has 
long been known. Many of the inborn errors of metabolism, such as gout   cystinuria, 
and primary hyperoxaluria, provide good examples of hereditary disease characterized 
by excessive production and excretion of stone -forming substances.
55 
    
    In underdeveloped countries nephrolithiasis is rare. In Britain and USA the 
incidence of renal calculi has become at least 10 times higher in the past 90 years. This 
increase may be related to changes in diet e.g. increase in protein diet. Current annual 
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incidence in Britain and the USA ranges from 6.87 to 20.8 per 10,000 of the 
population. A familial tendency toward stone formation has long been recognized 
 If stones grow to sufficient size (usually at least 3 millimeters (0.12 in)) they 
can cause obstruction of the ureter. Ureteral obstruction causes postrenal azotemia and 
hydronephrosis (distention and dilation of the renal pelvis and calyces), as well as 
spasm of the ureter. This leads to pain, most commonly felt in the flank (the area 
between the ribs and hip), lower abdomen, and groin (a condition called renal colic). 
Renal colic can be associated with nausea, vomiting, fever, blood in the urine, pus in 
the urine, and painful urination. Renal colic typically comes in waves lasting 20 to 60 
minutes, beginning in the flank or lower back and often radiating to the groin or 
genitals. The diagnosis of kidney stones is made on the basis of information obtained 
from the history, physical examination, urinalysis and radiographic studies. Ultrasound 
examination and blood tests may also aid in the diagnosis.
56
 
Renal calculi are formed when the urine is supersaturated with salt and 
minerals such as calcium oxalate, struvite (ammonium magnesium phosphate), uric 
acid and cystine.60-80% of stones contain calcium
57
. They vary considerably in size 
from small 'gravel-like' stones, to large staghorn calculi. The calculi may stay in the 
position in which they are formed, or migrate down the urinary tract, producing 
symptoms along the way. Studies suggest that the initial factor involved in the 
formation of a stone may be the presence of nanobacteria that form a calcium 
phosphate shell
58,59.
. 
The other factor that leads to stone production is the formation of Randall's 
plaques. Calcium oxalate precipitates form in the basement membrane of the thin 
loops of Henle; these eventually accumulate in the subepithelial space of the renal 
papillae, leading to a Randall's plaque and eventually a calculus.
60
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Pathophysiology 
 
                        
 
       Urinary calculi are consist of aggregates of crystals, usually containing calcium or 
phosphate in combination with small amounts of proteins and glycoproteins. In 
developed countries, however, most calculi occur in healthy young men, in whom 
investigations reveal no clear predisposing cause. Renal stones vary greatly in size. 
There may be particles like sand anywhere in the urinary tract, or large round stones in 
the bladder.  
 
       In developing countries bladder stones are common, particularly  in  children. In 
developed countries, the incidence of childhood bladder stones is low; renal stones in 
adults are more common. Staghorn calculi fill the whole renal pelvis and branch into 
the calyces; they are usually associated with infection and composed largely of 
struvite.  
 
      Deposits of calcium may be present throughout the renal parenchyma, giving rise 
to fine calcification within it (nephrocalcinosis), especially in patients with renal 
tubular acidosis, hyperparathyroidism, vitamin D intoxication and healed renal 
tuberculosis. Cortical nephro calcinosis  may occur in areas of cortical necrosis, 
typically after AKI in pregnancy or other severe AKI. 
PREVALENCE 
      Renal stone disease is common , affecting individuals of all countries and ethnic 
groups. In the UK, the prevalence is about 1.2%, with a lifetime risk of developing a 
renal stone at age 60-70% of about 7% in men. In some regions the risk is higher, most 
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notably in countries like Saudi Arabia, where the lifetime risk of developing a renal 
stone in men aged 60-70 is just over 20%
61
.  
EPIDEMIOLOGY 
 Renal stones are common, being present at some time in one in ten of the 
population, although a significant proportion will remain asymptomatic. 
 The annual incidence is about 1-2 cases of acute renal colic per 1,000 people 
and the average lifetime risk around 5-10%. 
 Men are more commonly affected than women, with a male to female ratio of 
3:1. The difference between the sexes is gradually being eroded. This is 
thought to be due to lifestyle-associated factors, such as obesity and a Western 
diet. 
 The peak age for developing stones is between 30 and 50 and recurrence is 
common
57
. 
ETIOLOGY AND PATHOGENESIS 
   The crystals in the stone in the kidney are commonly mixed, although there is 
usually a preponderance of crystals from one particular solute. 70-75% of renal stones 
are composed almost entirely of calcium oxalate, mixed with calcium phosphate. 15% 
of calculi consist predominantly of magnesium ammonium phosphate (struvite). Uric 
acid stones and cysteine stones together account for about 10% of calculi. Very rarely 
stones are made up of almost pure xanthine, silica or some chemical foreign to the 
body. 
Uric acid crystals are commoner in some parts of the Middle East, India and 
North Africa than in Europe and the USA. 
The formation of stones within the kidney is not a specific disease, it is 
potential complication of many different disorders. The cause is obscure. The most 
important is almost certainly an increased urine concentration of the some 
constiuents
62
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TYPES OF RENAL CALCULI 
 
                                   
  There are  4 main tyoes of renal calculi- calcium containing, mixed(struvite), uric 
acid and cysteine stones, a few rare types. 
1) CALCIUM STONES 
                                   
 
        Calcium stones are the most common comprising about 75% of all urinary 
calculi. They may be pure stones of calcium oxalate (50%), or calcium phosphate 
(5%), or mixture of calcium oxalate and calcium phosphate (45%). 
Etiology 
    Etiology  of calcium stones are variable. 
About 50% of patients with calcium stones have idiopathic hypercalciuria 
without hypercalcaemia.  
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Approximately 10 % cases are associated with hypercalcaemia and 
hypercalciuria, the most commonly due to hyperparathyroidism, or a defect in the 
bowel (i.e. absorptive hypercalciuria), or in the kidney (i.e. renal hypercalciuria). 
About 15% of patients with calcium stones have hyperuricosuria with a 
normal blood uric acid level and without any abnormality of calcium metabolism. 
In about 25% of patients with clcium stones, the cause is known as there is no 
abnormality in urinary excretion of calcium, uric acid or oxalate and is referred to as 
idiopathic calcium stone disease. 
 Pathogenesis  
     The mechanism of calcium stone formation is explained on the basis of 
imbalance between the degree of supersaturation of the ions forming the stone and the 
concentration of inhibitors in the urine. Most likely site where the crystals of calcium 
oxalate and / or calcium phosphate are precipitated is the tubular lining or around 
some fragment of debris  in the tubule acting as nidus of the stone. The predisposing 
factors contributing to formation of calcium stones are alkaline pH, decreased urinary 
volume and increased excretion of oxalate and uric acid 
Morphology  
      Calcium stones are usually small (less than a centimeter), ovaid, hard, with 
granular rough surface. They are dark brown due to old blood pigment deposited in 
them as a result of repeated trauma caused to the urinary tract by these sharp – edged 
stones. 
2.MIXED STONES 
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About 15% of urinary calculi are made of magnesium-ammonium-calcium 
phosphate, often called struvite; hence mixed stones are also called as struvite stones 
or triple phosphate stones. 
Etiology  
Struvite stones are formed as a result of infection of the urinary tract with urea- 
splitting organisms that produce urease such as by specious of Proteus, and 
occasionally klebsiella, pseudomonas, and  Enterobacter. these are, therefore, also 
known as infection – induced stones. However, E.coli does not form urease. 
Morphology  
      Struvite stones are yellow- white or grey. They tend to be soft and irregular in 
shape. Staghorn stone which is large, solitary stone that takes the shape of the renal 
pelvis where it is often formed is an example of struvite stone
63
 
 
3).URIC ACID STONES  
                           
Approximately 6% of urinary calculi are made of uric acid. Uric acid calculi 
are radiolucent unlike radio- opaque calcium stones. 
Etiology  
Uric acid stones are frequently formed in cases with hyperuricaemia and 
hyperuricosuria such as due to primary gout or secondary gout due to 
myeloproliferative disorders        (e.g. in  leukaemias), especially those on 
chemotherapy, and administration of uricosuric drugs (e.g. salicylates, probenacid). 
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Other factors contributing to their formation are acidic urinary pH (below 6) and low 
urine volume. 
Pathogenesis 
    The solubility of uric acid at pH of 7 is 200 mg/ dl while at pH of 5 is 15 mg 
/dl. Thus as the urine becomes more acidic, the solubility of uric acid in urine 
decreases and precipitation of uric acid crystals increases favoring the formation of 
uric acid stones. Hyperuricosuria is the most important factor in the production of uric 
acid stones, while hyperuricaemia is found in about half the cases. 
Morphology  
Uric acid stones are smooth, yellowish- brown, hard and often multiple. On cut 
section, they show laminated structure. 
4).CYSTINE STONES  
 
                              
 
Cysteine stones comprise less than 2% of urinary calculi. 
 Etiology  
Cysteine are associated with cystinuria due to a genitically- determined defect 
in the transport of cysteine and other amino acids across the cell membrane of the 
renal tubules and the small intestinal mucosa. 
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Pathogenesis  
The resultant excessive excretion of cysteine which is least soluble of the 
naturally- occurring amino acids leads to formation of crystals and eventually cysteine 
calculi. 
Morphology  
cysteine  stones are small, rounded, smooth and multiple. They are yellowish 
and waxy. 
5.OTHER CALCULI 
Less than 2% of urinary calculi consist of other rare types such as due to 
inherited abnormality of enzyme metabolism e.g. hereditary xanthinuria developing 
xanthine stones
64
. 
  CLINICAL COURSE 
     Stones are of importance when they obstruct urinary flow or produce 
ulceration and bleeding. They may be present without producing any symptoms or 
significant renal damage. In general, smaller stones are most hazardous, as they may 
pass into the ureters, producing pain referred to as colic (one of the most intense forms 
of pain) as well as ureteral obstruction. Larger stones cannot enter the ureters and are 
more likely to remain silent within the renal pelvis. Commonly, these larger stones 
first manifest themselves by hematuria. Stones also predispose to superimposed 
infection, both by their obstructive nature and by the trauma they produce
65
.  
MORPHOLOGY OF KIDNEY 
     In 80% of patients, stones are unilateral. Common sites are renal pelvis, 
calyces and the bladder. Calcium oxalate crystals are mostly unilateral and solitary. 
They are usually either yellow-brown or dark from altered blood, and hard. 
Predominantly oxalate calculi may be nodular with smaller blunt spikes; mixed 
oxalate and phosphate stones may be fairly smooth. If small they are triangular in 
section. The nodular form may be called mulberry type in Britain or the jackstone type 
in the USA. Occasionally progressive accretion of salts leads to the development of 
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branching structures known as staghorn  calculi, which create a cast of the renal pelvic 
and calyceal system. These massive stones are usually composed of magnesium 
ammonium phosphates
62
.  
CLINICAL FEATURES    
  The clinical presentation is highly variable. Most patients with renal stone 
disease are asymptomatic, whereas others present with pain, hematuria, UTI, or 
urinary tract infection.  
    A common presentation is with acute loin pain radiating to the anterior 
abdominal wall, together with hematuria; a symptom complex termed renal or ureteric 
calculi. This most commonly caused by a calculus but the same symptoms can occur 
in association with a sloughed renal papilla, tumour or blood clot. 
     The patient is suddenly aware of pain in the loin, which radiates round the 
flank to the groin and often into the testis or labium, in the sensory distribution of the 
first lumbar nerve. The pain steadily increase in intensity to reach a peak in a few 
minutes.  
   The patient is restless and generally tries unsuccessfully to obtain relief by 
changing position or packing the room. There is pallor, sweating, and often vomiting. 
Frequency, dysuria, and hematuria may occur. The intense pain usually subsides 
within 2 hours but may continue unabated for hours or days
61
.  
PRESENTATION   
 Many stones are asymptomatic and discovered during investigations for other 
conditions. 
 The classical features of renal colic (or ureteric colic) are sudden severe pain. It 
is usually caused by stones in the kidney, renal pelvis or ureter, causing 
dilatation, stretching and spasm of the ureter. In most cases no cause is found: 
 Pain starts in the loin about the level of the costovertebral angle (but 
sometimes lower) and moves to the groin, with tenderness of the loin or renal 
angle, sometimes with haematuria. 
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 If the stone is high and distends the renal capsule then pain will be in the flank 
but as it moves down pain will move anteriorly and down towards the groin. 
 A stone that is moving is often more painful than a stone that is static. 
 The pain radiates down to the testis, scrotum, labia or anterior thigh. 
 Whereas the pain of biliary or intestinal colic is intermittent, the pain of renal 
colic is more constant but there are often periods of relief or just a dull ache 
before it returns. The pain may change as the stone moves. The patient is often 
able to point to the place of maximal pain and this has a good correlation with 
the current site of the stone. 
       Other symptoms which may be present include:  
 Rigors and fever. 
 Dysuria. 
 Haematuria. 
 Urinary retention. 
 Nausea and vomiting
57
. 
PREDISPOSING FACTORS FOR KIDNEY STONES 
Environmental and dietary: 
 Low urine volumes, high ambient temperatures, low fluid intake 
 Diet: high protein intake, high sodium, low calcium 
 High sodium excretion 
 High urate excretion 
 High oxalate excretion 
 Low citrate excretion 
Acquired causes: 
 Hypercalcemia of any cause 
 Ileal disease or resection (leads to increased oxalate absorption and urinary 
excretion) 
 Renal tubular acidosis type I 
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Congenital and inherited causes: 
 Familial hypercalciuria 
 Renal tubular acidosis type I (distal) 
 Medullary sponge kidney 
 Cystinuria 
 Primary hyperoxaluria 
The majority of stones pass spontaneously within 48 hours. However, some 
stones may not. There are several factors which influence the ability to pass a stone. 
These include the size of the person, prior stone passage, prostate enlargement, 
pregnancy, and the size of the stone. A 4 mm stone has an 80% chance of passage 
while a 5 mm stone has a 20% chance. If a stone does not pass, certain procedures 
(usually by a urology specialist doctor) may be needed
66
.  
RISK FACTORS 
Several risk factors are recognised to increase the potential of a susceptible individual 
to develop stones. These include: 
 Anatomical anomalies in the kidneys and/or urinary tract - eg, horseshoe 
kidney, ureteral stricture. 
 Family history of renal stones. 
 Hypertension. 
 Gout. 
 Hyperparathyroidism. 
 Immobilisation. 
 Relative dehydration. 
 Metabolic disorders which increase excretion of solutes - eg, chronic 
metabolic acidosis, hypercalciuria, hyperuricosuria. 
 Deficiency of citrate in the urine. 
 Cystinuria (an autosomal-recessive aminoaciduria). 
 Drugs - eg, diuretics such as triamterene and calcium/vitamin D 
supplements. 
 More common occurrence in hot climates. 
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 Increased risk of stones in higher socio-economic groups. 
 Contamination - as demonstrated by a spate of melamine-contaminated 
infant milk formula
67
. 
EXAMINATION 
 The patient with colic of any sort writhes around in agony. This is in contrast 
to the patient with peritoneal irritation who lies still. 
 The patient is apyrexial in uncomplicated renal colic (pyrexia suggests 
infection and the body temperature is usually very high with pyelonephritis). 
 Examination of the abdomen can sometimes reveal tenderness over the 
affected loin. Bowel sounds may be reduced. This is common with any severe 
pain. 
 There may be severe pain in the testis but the testis should not be tender. 
 Blood pressure may be low. 
 Full and thorough abdominal examination is essential to check for other 
possible diagnoses - eg, acute appendicitis, ectopic pregnancy, aortic 
aneurysm
57.
 
DIFFERENTIAL DIAGNOSIS  
   This depends upon the position of the pain and the presence or absence of pyrexia 
and includes: 
 Biliary colic. 
 Pyelonephritis: very high temperature. Pain is unlikely to radiate to the groin. 
 Acute pancreatitis 
 Acute appendicitis 
 Perforated peptic ulcer. 
 Epididymo – orchitis or torsion of the testis: very tender testis. 
 Sinister causes of back pain: usually tender over vertebrae. 
 Dissection of an aortic aneurysm: the patient who presents with features of 
renal colic for the first time over the age of 60. This may be dissection of aortic 
aneurysm leading to ruptured aortic aneurysm.  
                                                                                 REVIEW OF LITERATURE 
 
Karpoora silasathu parpam for Kalladaippu Page 54 
 
 Drug addiction: there are reports of people with fictitious stories of renal colic, 
designed to obtain an injection of pethidine. These patients tend to be abusive 
when offered anything other than pethidine
68.
 
INVESTIGATIONS 
Basic analysis should include: 
 Blood for FBC, CRP, renal function, electrolytes, calcium, phosphate and 
urate, creatinine. 
 Midstream specimen of urine for microscopy (pyuria suggests infection), 
culture and sensitivities. 
 Prothrombin time and international normalised ratio if intervention is planned. 
 Stick testing of urine for red cells (suggestive of urolithiasis), white cells and 
nitrites (both suggestive of infection) and pH (pH above 7 suggests urea-
splitting organisms such as Proteus spp. whilst a pH below 5 suggests uric acid 
stones). 
  Intravenous pyelogram (IVP)
69
 . 
 Computed tomography (CT) 
  Ultrasound scanning may be helpful to differentiate radio-opaque from 
radiolucent stones and in detecting evidence of obstruction. 
 Plain X-rays of the kidney, ureter and bladder (KUB) are useful in watching 
the passage of radio-opaque stones (around 75% of stones are of calcium and 
so will be radio-opaque). 
 The European Association of Urology's guidelines on urolithiasis recommend 
stone analysis for: 
 All first-time stone formers. 
 All patients with recurrent stones who are on pharmacological preventing 
therapy. 
 Patients who have had early recurrence after complete stone clearance. 
 Late recurrence after a long stone-free period (stone composition may 
change)
70
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COMPLICATIONS  
  The complications of calcium oxalate and hydroxyapatite renal calculi are acute and 
chronic pyelonephritis, hydronephrosis and obstructive nephropathy.  
  The stone fragments may obstruct the ureter. This occurs in 5-15% of cases. 8% of 
patients develop hypertension or exacerbation of pre- existing hypertension within 1 
year. thirdly there is a risk of renal damage.  
  HYDRONEPHROSIS 
   In bilateral complete obstruction, patient present with anuria.  When the obstruction 
is below the bladder the dominant symptoms are bladder distention. Unilateral 
hydronephrosis may remain completely silent for long periods of time. Enlargement of 
kidney is made out on physical examination. Sometimes the obstructing cause e.g. 
calculi can produce symptoms. 
Early removal of the cause of obstruction can return the full function of the kidney. In 
long standing cases the changes become irreversible. 
Two metabolic disorders need to be mentioned here which are associated with 
precipitation of the crystalline material causing obstruction to urine flow. 
1.HYPERURICAEMIA 
 Uric acid stones are formed In 22% of patients with gout. The urate crystals get 
deposited in distal collecting tubules.  Collecting ducts as well in the interstitium, 
forming gouty tophus. Uric acid  crystal deposition takes place also following 
chemotherapy to the patients of leukemia and lymphoma. this is due to the breaking 
down of nucleic acid.  
2.HYPERCALCAEMIA 
 Hyperparathyroidism, end stage kidney disease, vit. D intoxication, excessive calcium 
intake, osteolytic disease of bones, milk- alkali syndrome are some of the conditions 
giving rise to hypercalcaemia. This induces deposition of calcium in renal tubules 
called nephrocalcinosis.  Sometimes, the deposition can also form renal stones
62
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Complete blockage of the urinary flow from a kidney decreases glomerular filtration 
rate (GFR) and, if it persists for more than 48 hours, may cause irreversible renal 
damage. 
If ureteric stones cause symptoms after four weeks, there is a 20% risk of 
complications, including deterioration of renal function, sepsis and ureteric stricture. 
Infection can be life-threatening. 
Persisting obstruction predisposes to pyelonephritis
70
. 
PROGNOSIS 
  The prognosis will depend upon the underlying condition causing the renal stones. 
Calcium oxalate and hydroxyapatite stones per se rarely lead to renal failure. If at the 
time of diagnosis there is renal damage due to the calculi then this may cause renal 
dysfunction and hypertension. The main problem is recurrence unless the causative 
condition can be treated ; the recurrence rate is high, approaching 70% by 10 years 
after spontaneous passage or surgical removal of a calculus
71
. 
 Most symptomatic renal stones are small (less than 5 mm in diameter) and pass 
spontaneously. 
 Stones less than 5 mm in diameter pass spontaneously in up to 80% of people. 
 Stones between 5 mm and 10 mm in diameter pass spontaneously in about 50% of 
people. 
 Stones larger than 1 cm in diameter usually require intervention (urgent 
intervention is required if complete obstruction or infection is present). 
 Two thirds of stones that pass spontaneously will do so within four weeks of onset 
of symptoms. 
 A stone that has not passed within 1-2 months is unlikely to pass spontaneously. 
 The following features predispose to recurrent stone formation: 
 First attack before 25 years of age. 
 Single functioning kidney. 
 A disease that predisposes to stone formation. 
 Abnormalities of the renal tract. 
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PREVENTION 
Recurrence of renal stones is common and therefore patients who have had a renal 
stone should be advised to adapt and adopt several lifestyle measures which will help 
to prevent or delay recurrence: 
 Increase fluid intake to maintain urine output at 2-3 litres per day. 
 Reduce salt intake. 
 Reduce the amount of meat and animal protein eaten. 
 Reduce oxalate intake (foods rich in oxalate include chocolate, rhubarb, nuts) 
and urate-rich foods (eg, certain fish). 
 Drink regular cranberry juice: increases citrate excretion and reduces oxalate 
and phosphate excretion. 
CALCIUM 
 Maintain good calcium intake(calcium forms an insoluble salt with dietary 
oxalate, lowering oxalate absorption and excretion). 
 Avoid calcium supplements separate from meals (increase calcium excretion 
without reducing oxalate excretion).  
OXALATE 
    Depending on the composition of the stone, medication to prevent further stone 
formation is sometimes given - eg, thiazide diuretics (for calcium stones),allopurinol 
(for uric acid stones) and calcium citrate (for oxalate stones)
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INGREDIENTS 
• Karpoora silasathu (Gypsum) 
• Venkaram (Borax) 
• Paruththi samoola champal (Gossypium herbaceum) 
• Thuththi ver (Abutilon indicum) 
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ACTIONS OF TRIAL DRUGS 
 
S.No Drugs Botanical name Actions 
1 Karpoora silasathu (Gypsum) Diuratic 
Lithontriptic 
Astringent
72 
2 Venkaram (Borax) Diuratic 
Lithontriptic 
Refrigerant
73 
3 Paruththi samoola champal Gossypium herbaceum Demulcent  
Astringent  
Diuratic
74 
4 Thuththi ver Abutilon indicum Tonic  
Diuratic 
Laxative
75 
 
 
STANDARD OPERATIVE PROCEDURE 
Take karpoora silasathu and venkaaram (35 gms each) and grind them with 
decoction of paruthi chedi saambal and thuththi ver thol for 24 hours, make it paste 
and dry and calcinate with five cow dungs. 
 Then grind it again with white egg yolk, make it into paste and dry, calcinate 
with 5 cow dungs. Repeat the process for five times.
76 
 
DOSAGE 
 130 mg, bid after food 
 
ADJUVANT 
 Ilaneer 
 
DURATION 
 1 Mandalam (48 days) 
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INGREDIENTS OF TRIAL DRUG 
Before purification 
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    AFTER PURIFICATION 
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MATERIALS AND METHODS 
 
PROTOCOL 
 
Study Design 
 A clinical study on kalladaippu was carried out in the Post graduate 
Department of Maruthuvam in Govt.Siddha Medical College attached to Arignar Anna 
Hospital of Indian Medicine, Chennai – 106 during the period of 2015 – 2017. 
 The study was approved by Instititional Ethics Committee (IEC) and the 
approval number is GSMC-CH-ME-4/2015/010. It was registered in Clinical Trials 
Registry – India (CTRI) and the register number is CTRI/2017/04/008435. 
  
Sample size 
 The study is conducted in 40 selected kalladaippu patients of both genders 
between age groups of 18 to 60 years. 
 
Selection Criteria 
 
 The patients having following parameters are selected for the study. 
 
 Pain in the flank  
 
 Burning Micturition 
  
 Oliguria 
  
 Dysuria  
 
 Nausea  
 
 Vomiting  
 
  Haematuria  
 
 Fever  
 
 History of Urolithiasis (with USG-Whole Abdomen reports)  
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Exclusion Criteria 
 
 Age group less than 18 
 Stag horn calculus 
 Pyonephrosis 
 Calculi associated with elevated serum creatinine level 
 Calculi in pregnancy 
 
Proforma  
 The case sheet proforma for kalladaippu was prepared based on Siddha 
Diagnostic methodology with necessary modern techniques. 
 
History taking 
 For better treatments and results a detailed clinical history was taken regarding  
present illness, past illness, family history, menstrual history, occupational history, 
socio economic status, residential area, etc., 
 
Investigation 
 All patients were screened by the following investigations. This was carried 
out regularly before and after treatment. 
 
 Blood for biochemical examination 
The blood was tested for sugar, urea, serum creatinine to know the renal function and 
its excretion. 
 
 Urine Examination 
         Albumin, Sugar, Deposits. 
 
 Ultra sonogram 
Ultra sonogram of complete abdomen including KUB was done in cases to know the 
location, size and number of calculi. 
 
Drug and dose schedule 
 Karpoora silasathu parpam – 130 mg, bid after food with Ilaneer for 48 days.  
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RESULTS AND OBSERVATION 
 40 cases having Kalladaippu were selected and treated in OPD of PG 
Maruthuvam Department attached to AAGHIM, Chennai – 106 during the year 2015 – 
2017. The result and observation during that clinical study are as follows. 
 Gender distribution 
 Age distribution 
 Occupation 
 Socio- economic status 
 Dietary habits 
  Seasonal occurence 
 Distribution of thinai 
 Distribution of mukkutram – vatham 
 Distribution of mukkutram – pitham  
 Distribution of mukkutram – kabham 
 Ezhu udal thathukkal 
 En vagai thervugal 
 Naadi 
 Neikuri 
 Clinical features 
 Clinical prognosis 
 Distribution of calculi based on location 
 Grading of results 
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GENDER DISTRIBUTION 
 
S.No GENDER NUMBER OF CASES PERCENTAGE (%) 
1 Male 23 57.50% 
2 Female 17 42.50% 
 
 
 
INFERENCE 
 About 57.5% were males and 42.5% were females 
 Literature: according to literature males are more prone to renal calculi 
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AGE DISTRIBUTION 
 
S.No AGE IN YEARS NUMBER OF 
CASES 
PERCENTAGE (%) 
1 18 – 20 yrs 0 0% 
2 21 - 30 yrs 3 7.5% 
3 31 - 40 yrs 21 52.5% 
4 41 - 50 yrs 9 22.5% 
5 51 - 60 yrs 7 17.5% 
 
 
 
INFERENCE 
 Majority of the case that is 52.5% were in the  3rd decade, 22.5% were in the 4th 
decade, 7.5% were in the2
nd
 decade, 17.5% were in the 5
th
 d 
ecade. 
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OCCUPATION 
S.No OCCUPATION NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Office worker 11 27.5% 
2 House Wife 14 35% 
3 Business 4 10% 
4 Student 2 5% 
5 Others(Coolies) 9 22.5% 
 
 
 
INFERENCE 
 0ut of 40 patients (100%), 35% were house wife, 27.5% were office 
worker,10% were business and student 5%, 22.5% were in other occupation. 
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SOCIO – ECONOMIC STATUS 
S.No SOCIO – ECONOMIC 
STATUS 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Low Income  
( below 200,000 per annum) 
24 60% 
2 Moderate Income  
(200,000 – 500,000 per 
annum) 
10 25% 
3 High Income  
( Above 500,000 per annum) 
6 15% 
 
 
 
INFERENCE: 
 Among 40 cases 60% comes under low economic status, 25% of them under 
moderate status and 15% of them under high income status. 
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DIETARY HABITS 
S.No DIET NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vegetarian 5 12.5% 
2 Mixed diet 35 87.5% 
 
 
 
INFERENCE 
 Among 40 patients, five patients (12.5%) were taking vegetarian food and 35 
patients were taking mixed diet. 
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SEASONAL OCCURENCE 
S.No KAALAM (Season) NUMBER OF CASES PERCENTAGE (%) 
1 Kaar kaalam 
( Mid Aug – Mid Oct) 
4 10% 
2 koothir Kaalam 
(Mid Oct – Mid Dec) 
6 15% 
3 Munpani kaalam 
(Mid Dec – Mid Feb) 
7 17.5% 
4 Pinpani kaalam 
(Mid Feb – Mid Apr) 
0 0% 
5 Elavenir kaalam 
(Mid Apr – Mid Jun) 
8 20% 
6 Muthuvenir kaalam 
(Mid Jun – Mid Aug)  
15 37.5% 
 
 
INFERENCE 
 According to paruvakaalam highest incident of 15 cases (37.5%) were noted in 
muthuvenir kaalam and 8 cases (20%) were noted in elavenir kaalam, 6 cases (15%) 
were noted in koothir kaalam, 4 cases (10%) were noted in kaar kaalam . 
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DISTRIBUTION OF THINAI 
S.No THINAI NUMBER OF CASES PERCENTAGE (%) 
1 Kurinji 0 0% 
2 Mullai 0 0% 
3 Maruthuvam 4 10% 
4 Neithal 36 90% 
5 Paalai 0 0% 
 
 
 
 
INFERENCE 
 According to thinai the highest distribution 90 % was noted in neithal, 10% in 
marutham . 
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DISTRIBUTION OF MUKKUTRAM – VATHAM 
S.No VATHAM NUMBER OF CASES PERCENTAGE (%) 
1 Pranan 0 0% 
2 Abanan 40 100% 
3 Viyanan 40 100% 
4 Uthanan 12 30% 
5 Samanan 0 0% 
6 Nagan 0 0% 
7 Koorman 0 0% 
8 Kirukaran 0 0% 
9 Devathathan 11 27.5% 
10 Thananjeyan 0 0% 
 
 
INFERENCE  
Out of 40 patients Abanan was affected in 40 patients (100%), Viyanan was affected 
in 40 pateints (100%), Uthanan was affected in 12 patients (30%), and Devathathan 
was affected in 11 patients(27.5). 
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DISTRIBUTION OF MUKKUTRAM – PITHAM 
S.No PITHAM NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Analagam 0 0% 
2 Ranjagam 9 22.5% 
3 Saathagam 40 100% 
4 Alosagam 0 0% 
5 Pirasagam 0 0% 
 
 
 
 
INFERENCE 
 Out of 40 patients Ranjagam was affected in 9 patients (22.5%),Sathagam was 
affected in 40 patients (100%). 
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DISTRIBUTION OF MUKKUTRAM – KABHAM 
 
S.No KABHAM NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Avalambagam 0 0% 
2 Klethagam 0 0% 
3 Pothagam 0 0% 
4 Tharpagam 0 0% 
5 Santhigam 12 30% 
 
 
 
 
 
 
INFERENCE 
 
Out of 40 patients, Santhigam was affected in12 patients (30%). 
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EZHU UDAL THATHUKAL 
 
S.No EZHU UDAL 
THATHUKAL 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Saaram 40 100% 
2 Senneer 9 22.5% 
3 Oon 0 0% 
4 Kozhupu 0 0% 
5 Enbu 12 30% 
6 Moolai 0 0% 
7 Sukkilam /Suronitham 0 0% 
 
 
 
 
 
INFERENCE 
 
 Out of 40 patients, Saaram was affected in 40 patients (100%), Senneer was 
affected in 9 patients (22.5%), Enbu was affected in 12 patients (30%). 
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EN VAGAI THERVUGAL 
 
S.No EN VAGAI 
THERVUGAL 
NUMBER OF CASES PERCENTAGE (%) 
1 Naa 0 0% 
2 Niram 9 22.5% 
3 Mozhi 0 0% 
4 Vizhi 4 10% 
5 Sparisam 7 17.5% 
6 Malam 1 2.5% 
7 Moothiram 40 100% 
 
 
 
 
 
 
INFERENCE 
 
In Envagai thervu , Niram was affected in 9 patients (22.5), Vizhi was affected in 4 
patients (10%), Sparisam was affected in 7 patients (17.5%), Malam was affected in 1 
patient (2.5%) and Moothiram was affected in 40 patients (100%). 
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NAADI 
 
S.No NAADI NUMBER OF CASES PERCENTAGE (%) 
1 Vali Azhal 24 60% 
2 Azhal Vali 11 27.5% 
3 Kabha Vatham 2 5% 
4 Kabha Pitham 3 7.50% 
 
 
 
 
 
 
INFERENCE 
 
 24 patients (60%) had Vali azhal naadi, 11 patients (27.5%) had Azhal vali 
naadi, 2 patients (5%) had Kabha vatha naadi and 3 patients (7.5%) had Kabha pitha 
naadi. 
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NEIKURI 
 
S.No THATHU NEIKURI NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vatha neer Spread like snake 11 27.5% 
2 Pitha neer Spread like ring 25 62.5% 
3 Kabha neer Spread like pearl 4 10% 
 
 
 
 
 
 
INFERENCE 
 
 25 patients (62.5%) had Pitha neer, 11 patients (27.5%) had vatha neer, and 5 
patients (10%) had Kabha neer. 
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CLINICAL FEATURES 
 
S.No SIGNS & SYMPTOMS NUMBER OF CASES PERCENTAGE (%) 
1 Flank pain 40 100% 
2 Nausea 6 15% 
3 Vomitting 2 5% 
4 Burning Micturition 18 45% 
5 Dysuria 2 5% 
6 Oliguria 12 30% 
7 Fever 4 10% 
8 Retention 0 0% 
9 Hematuria 0 0% 
 
 
 
 
 
INFERENCE 
 
 Out of 40 patients, 40 patients (100%) had Flank pain, 6 patients (10%) had 
Nausea, 2 patients (5%) had vomiting ,18 patients (45%) had Burning Micturition, 2 
patients (5%) had Dysuria, 12 patients (30)  had Oliguria, 4 patients (10%) had Fever, 
and No patients had Hematuria. 
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CLINICAL PROGNOSIS 
 
 
S.No SIGNS& 
SYMPTOMS 
BEFORE TREATMENT AFTER TREATMENT 
NO.OF 
CASES 
PERCENTAGE 
(%) 
NO.OF 
CASES 
PERCENTAGE 
(%) 
1 Flank pain 40 100% 5 12.5% 
2 Nausea 6 15% 0 0% 
3 Vomiting 2 5% 0 0% 
3 Burning Micturition 18 45% 2 5% 
4 Dysuria 2 5% 0 0% 
5 Fever 4 10% 0 0% 
6 Oliguria  12 30% 0 0% 
 
CLINICAL PROGNOSIS 
 
 
 
 
INFERENCE 
 After treatment Flank pain present in 5 patients (12.5%), Burning Micturition 
present in 2 patients (5%). No patients have experienced Nausea, Vomiting, Dysuria, 
Fever and Hematuria 
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DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
SIDE BEFORE TREATMENT AFTER TREATMENT 
NO.OF 
CASES 
PERCENTAGE 
(%) 
NO.OF 
CASES 
PERCENTAGE 
(%) Rt – Kidney 11 27.5% 4 10%
Lt – Kidney 10 25% 3 7.5% 
Bilateral 18 45% 9 22.5% 
Ureteral 1 2.5% 0 0% 
 
DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
 
 
 
INFERENCE 
 
Before treatment: 
Out of 40 patients, 18 patients (45%) were having bilateral renal calculi, 11 
patients 27%) were having right renal calculi, and 10 patients (25%) were having left 
renal calculi,1 patient (2.5%) having Ureteral calculi.  
After treatment: 
 Out of 40 patients, 9 patients (22.5%) were having bilateral renal calculi, 4 
patients (10%) having right renal calculi and 3 patients (7.5%) having left renal 
calculi. 
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GRADING OF RESULTS 
 
S.No GRADING NUMBER OF CASES PERCENTAGE (%) 
1 Good 17 42.5% 
2 Moderate 19 47.5% 
3 Poor 4 10% 
 
 
 
 
INFERENCE 
  
Out of 40 patients, 17 cases (42.5%) shows good result, 19 cases (47.5%) shows 
moderate result, 4 cases (10%) shows poor result. 
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LIST OF PATIENTS 
 
S.no Op. no Patient’s name Age/Sex Occupation Date of 
Medicine 
Started 1 6126 Mr.kumar 35/M IT Profession 20-05-16 
2 6238 Mrs.Rajeswari 36/F House wife 22-05-16 
3 6243 Mr. Ilango 37/M IT Profession 22-05-16 
4 2516 Mrs.Lalitha 31/F House wife 25-05-16 
5 5986 Mr.saravanan 32/M Watchman 27-05-16 
6 2093 Mr. karuppaiya 40/M Clerk 29-05-16 
7 8914 Mr.venkat 27/M Student 31-05-16 
8 8923 Mr.saravanan 42/M Business 04-06-16 
9 7981 Mr.chandran 46/M Bank cashier 17-06-16 
10 8123 Mrs.Mahalakshmi 40/F House wife 18-06-16 
11 6823  Mr .John 42//M Electrician  13-06-16 
12 8123 Mrs.suganya 36/F House wife 19-06-16 
13 7289 Mr.jabhar  31/M Farmer 20-06-16 
14  8855 Mr.mahalingam 40/M Painter 27-06-16 
15 9900 Mrs.vimala 37/F House wife 05-07-16 
16 8110 Mr. mahendran 33/M Mechanic 13-07-16 
17 7263 Mr.sundar 38/M Painter 21-07-16 
18 7464 Mr. karuppasamy 35/M Office work 30-07-16 
19 7632 Mrs , kokila 35/F House wife 01-08-16 
20 7704 Mrs.Rani 55/F House wife 01-08-16 
21 8002 Mr .manikandan 36/M Camera 
service 
03-08-16 
22 8223 Mr.tamilarasan 38/M Electrician  07-08-16 
23 8863 Mrs .jayabharathi 55/F House wife 10-08-16 
24 1452 Mr.karthikeyan 34/M Business 19-09-16 
25 4084 Mrs. Dhanalakshmi 42/F House wife 28-09-16 
26 6318 Mrs.Geethapandian 44/F House wife 06-10-16 
27 7954 Mrs. Lalitha 48/F House wife 13-10-16 
28 2669 Mrs. Lalitha 31/F Office work 01-11-16 
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29 629 Mr.mankandan 42/M IT profession 30-11-16 
30 1613 Mr .arunkumar 31/M Business 05-12-16 
31 2109 Mrs.valarmathi 28/F House wife 07-12-16 
32 1947 Mr. sreeramalu 48/M Farmer 07-12-16 
33 3451 Mrs. Gowri 50/F House wife 15-12-16 
34 8163 Mr.gaanam 24/M Student 26-12-16 
35 6430 Mr. Sathishbabu 37/M Auto driver 27-12-16 
36 8298 Mr.kumar 53/M Coolie 03-01-17 
37 5597 Mr.venkatesan 58/M Hostel warden 02-02-17 
38 6782 Mrs.tamilkodi 57/F Business 07-02-17 
39 7074 Mrs.valli 52/F Clerk 08-02-17 
40 7337 Mrs. Usha 58/F House wife 09-02-16 
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RESULTS OF PATIENTS BEFORE AND AFTER TREATMENT 
GOVT.SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE, CHENNAI 
 
S.No Name of the patient 
Age / Sex 
 OP.No Date of 
Treatment 
Started 
Duration 
of 
medicine 
taken 
Size of stone BT Prognosis Remarks 
1 Mr.kumar 35/M 6126 20-05-16 7- Weeks LT 7-8 mm USG Normal Completed 
2 Mrs.Rajeswari 36/F 6238 22-05-16 7- Weeks Bilateral 5mm,4mm USG Normal Completed 
3 Mr. Ilango 37/M 6243 22-05-16 7- Weeks Bilateral RT 5 
Stones (4mm, 
5mm), LT 7 (4mm) 
Bilateral RT 3 
Stones (4mm, 
5mm), 
LT(4.5mm) 
Referred to 
urologist 
4 Mrs.Lalitha 31/F 2516 25-05-16 7- Weeks LT 2(8mm, 3mm) LT (6mm) Symptoms 
reduced 
5 Mr .Saravanan 32/M 5986 27-05-16 7- Weeks RT 3 (3.5 mm) USG Normal Completed 
6 Mr. karuppaiya 40/M 2093 29-05-16 5- Weeks Bilateral RT 2 
(8mm, 4mm) LT 3 
(8mm, 6mm, 3mm) 
One stone 
expelled, RT 
5mm, LT 3 
(4mm,3mm) 
Advice to 
continue 
medicine 
7 Mr.karthikeyan 34/M 1452 31-05-16 7- Weeks Bilateral RT 5mm, 
LT 7.mm 
LT  3.5mm Symptoms 
relieved 
8 Mr.saravanan 42/M 8923 04-06-16 7- Weeks LT 3 (4.5mm, 4mm, 
3.5mm) 
LT 3mm Symptoms 
relieved 
9 Mr.chandran 46/M 7981 17-06-16 7- Weeks Bilateral RT 3 
(4mm), LT 2 
(3.5mm, 3mm) 
Bilateral RT2 
(4mm),LT 
2(3.5mm) 
Poor 
prognosis 
10 Mrs.Mahalakshmi 40/F 8123 18-06-16 7- Weeks Bilateral RT 5mm , 
LT 8mm,9mm 
RT (6mm) Symptoms 
reduced 
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11  Mr .John 42//M 6823 13-06-16 7- Weeks Bilateral LT 12mm, 
RT 2 (3mm) 
LT 12mm, RT 
3mm 
Poor 
prognosis 
12 Mrs.suganya 36/F 8123 19-06-16 7- Weeks Bilateral RT 3(4, 
4.5,3mm), LT 4 
(3mm) 
RT 2 (4, 3.5mm), 
LT 3 (3mm) 
Symptoms 
relieved 
13 Mr.jaffar  31/M 7289 20-06-16 7- Weeks RT 5.3mm, USG Normal Completed 
14 Mr.mahalingam 40/M 8855 27-06-16 7- Weeks Bilateral RT 5 
(4mm), LT 3.5mm 
RT 2(3,4mm) Symptoms 
relieved 
15 Mrs.vimala 37/F 9900 05-07-16 7- Weeks LT 2(4mm) USG Normal Completed 
16 Mr. mahendran 33/M 8110 13-07-16 7- Weeks RT 3 (4.5mm) USG Normal Completed 
17 Mr.sundar 38/M 7263 21-07-16 7- Weeks LT 3 (3.5,4mm) LT 4mm Symptoms 
reduced 
18 Mr. karuppasamy 35/M 7464 30-07-16 7- Weeks Bilateral RT 5 (4.5, 
3.5mm), LT 6 
(3.5mm) 
RT 2 (3mm), LT 
3 (3.5mm) 
Symptoms 
relieved 
19 Mrs , kokila 35/F 7632 01-08-16 7- Weeks Bilateral RT 4 (6, 5, 
4.5, 4mm), LT 2 (8, 
6mm) 
RT 5(4, 5mm), 
LT 2 (7, 4mm) 
Symptoms 
reduced 
 
20 Mrs.Rani 55/F 7704 01-08-16 7- Weeks RT 5 (4.5mm) USG Normal Completed  
21 Mr .manikandan 36/M 8002 03-08-16 7- Weeks RT 4 (5, 3.5mm) RT 2 (5, 3.5mm) Symptoms 
relieved 
22 Mr.tamilarasan 38/M 8223 07-08-16 7- Weeks LT 3 (3mm) USG Normal Completed 
23 Mrs .jayabharathi 55/F 8863 10-08-16 7- Weeks RT 4 (3.5mm) RT 2 (4mm) Symptoms 
relieved 
24 Mr.venkat 27/M 8914 19-09-16 7- Weeks Bilateral RT 5mm, 
LT 7.5mm 
LT 3mm Symptoms 
relieved 
25 Mrs. Dhanalakshmi 42/F 4084 28-09-16 7- Weeks RT 4 (3.5, 4mm),  USG Normal 
 
Completed  
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26 Mrs.Geethapandian 44/F 6318 06-10-16 7- Weeks LT 4mm USG Normal Completed  
27 Mrs. Lalitha 48/F 7954 13-10-16 7- Weeks RT 3 (3.5-4mm) RT 2 (3mm),  Symptoms 
relieved 
28 Mrs. Lalitha 31/F 2669 01-11-16 7- Weeks RT 3 (3-4mm) USG Normal Completed  
29 Mr.mankandan 42/M 629 30-11-16 7- Weeks Bilateral RT 3 (3.5, 
4mm), LT 4(3mm) 
USG Normal Completed  
30 Mr .arunkumar 31/M 1613 05-12-16 7- Weeks Bilateral RT 5 
(3.5mm), LT 6 
(3mm) 
RT 5(3mm), LT 4 
(3mm) 
Symptoms 
reduced 
31 Mrs.valarmathi 28/F 2109 07-12-16 7- Weeks Bilateral RT 
4mm,4mm ,  
LT 4 mm 
USG Normal Completed  
32 Mr. sreeramalu 48/M 1947 07-12-16 7- Weeks Upper ureteric 
calculus 1.1cm 
USG Normal Completed 
33 Mrs. Gowri 50/F 3451 15-12-16 7- Weeks LT 2 (3mm) USG Normal Completed 
34 Mr.gaanam 24/M 8163 26-12-16 7- Weeks LT VUJN 6mm,RT 
5mm 
 LT 4mm Symptoms 
reduced 
35 Mr. Sathishbabu 37/M 6430 27-12-16 7- Weeks RT 6mm USG Normal Completed  
36  Mr.kumar 53/M 8298 03-01-17 8- Weeks LT 5mm USG Normal Completed 
37 Mr.venkatesan 58/M 5597 02-02-17 7- Weeks RT 10mm RT (10mm) Poor 
prognosis 
38 Mrs.tamilkodi 57/F 6782 07-02-17 7- Weeks Bilateral RT 
2(6mm,9mm),LT 
2(3mm,4mm) 
RT 4mm,5mm Advice to 
continue 
medicine 
39 Mrs.valli 52/F 7074 08-02-17 7- Weeks Bilateral 5 (4, 
3.5mm) 
Bilateral 2 
(3.5mm) 
Symptoms 
reduced 
40 Mrs. Usha 58/F 7337 09-02-17 7- Weeks LT 2 (3-4mm) USG Normal Completed  
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LABORATORY INVESTIGATION REPORT 
 
BEFORE TREATMENT 
 
 
 
 
S.No 
 
 
OP.
No 
 
 
Name 
 
 
Age/Sex 
Haematological report RFT Urine Analysis 
 
TC 
cells/ 
cu.mm 
 
DC 
% 
   
ESR 
 Hb 
gms
% 
 
Urea 
mg/ 
dl 
 
Creatinine 
mg/dl 
 
Alb 
 
Sug 
 
Dep 
 P L E ½ hr 1 hr       
1 6126 Mr.kumar 35/M 8500 63 34 3 22 59 13.0 32 1.3 Nil ++ Opc 
2 6238 Mrs.Rajeswari 36/F 9100 64 34 2 4 19 7.8 34 0.8 Nil Nil Opc 
3 6243 Mr. Ilango 37/M 8100 58 39 3 23 57 12.6 23 0.8 + Nil Nil 
4 2516 Mrs.Lalitha 31/F 8500 63 34 3 18 43 10.7 24 1.0 Nil Nil Oec 
5 5986 Mr.saravann 32/M 9000 58 36 6 16 37 14.9 27 0.8 Nil Nil Nil 
6 2093 Mr. karuppaiya 40/M 8700 60 36 4 2 9 8.9 37 1.0 Nil Nil Opc 
7 8914 Mr.venkat 27/M 9200 56 39 5 28 54 14.2 34 1.3 Nil Nil Opc 
8 8923 Mr.saravanan 42/M 9000 58 40 2 13 43 12.9 30 0.8 Nil Nil Opc 
9 7981 Mr.chandran 46/M 7900 56 42 2 6 21 14.9 35 0.9 Nil + Oec 
10 8123 Mrs.priya 38/F 6300 63 32 5 16 29 15 26 0.7 Nil Nil Opc 
11 6823  Mr .John 42//M 8700 62 35 3 12 28 8.5 25 0.7 Nil Nil Nil 
12 8123 Mrs.suganya 36/F 9700 55 42 3 7 15 13 25 0.9 Nil Nil Nil 
13 7289 Mr.jabhar  31/M 9500 62 34 4 2 5 10.8 27 0.7 Nil Nil Nil 
14 8855 Mr.mahalingam 40/M 8900 61 36 3 5 12 9.8 26 0.7 Nil Nil Nil 
15 9900 Mrs.vimala 37/F 8400 52 44 4 15 20 10.1 25 0.8 Nil Nil Nil 
16 8110 Mr. mahendran 33/M 8500 60 37 3 4 7 13.2 20 0.7 Nil Nil Nil 
17 7263 Mr.sundar 38/M 8900 55 42 3 9 15 13 24 0.9 Nil Nil Oec 
18 7464 Mr. karuppasamy 35/M 8800 61 34 5 8 12 11.2 25 0.8 Nil Nil Nil 
19 7632 Mrs , kokila 35/F 8400 60 37 3 8 16 13 25 0.8 Nil Nil Opc 
20 7704 Mrs.Rani 55/F 9200 59 37 4 5 10 13 30 0.9 Nil Nil Nil 
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21 8002 Mr .manikandan 36/M 8900 58 39 3 8 12 13.5 31 1.1 Nil Nil Opc 
22 8223 Mr.tamilarasan 38/M 8900 61 36 3 5 9 12.8 24 0.7 Nil Nil Nil 
23 8863 Mrs .jayabharathi 55/F 9400 54 42 4 2 6 12.1 22 0.8 Nil Nil Nil 
24 1452 Mr.karthikeyan 34/M 8700 60 37 3 6 15 10.8 26 1.1 Nil Nil Nil 
25 4084 Mrs. Dhanalakshmi 42/F 10300 61 36 3 5 12 14.2 28 0.7 Nil Nil Nil 
26 6318 Mrs.Geethapandian 44/F 8300 58 39 3 5 13 13.2 22 0.8 Nil Nil Nil 
27 7954 Mrs. Lalitha 48/F 8600 59 37 4 7 16 11.2 24 0.8 Nil Nil Nil 
28 2669 Mrs. Lalitha 31/F 9700 56 40 4 2 4 12.5 28 0.9 Nil Nil Nil 
29 629 Mr.mankandan 42/M 8000 58 39 3 4 8 13.1 25 0.7 Nil Nil Nil 
30 1613 Mr .arunkumar 31/M 9700 56 41 3 5 10 12 26 0.7 Nil Nil Nil 
31 2109 Mrs.valarmathi 28/F 9700 63 33 4 5 10 11.6 29 0.8 Nil Nil Nil 
32 1947 Mr. kuppusamy 48/M 8400 50 46 4 4 8 10.9 24 0.9 Nil ++ Nil 
33 3451 Mrs. Gowri 50/F 8200 59 38 3 6 15 14.6 24 0.7 Nil Nil Nil 
34 8163 Mrs .gaanam 24/M 8500 62 35 3 10 20 14 26 0.8 Nil Nil Nil 
35 6430 Mr. Sathishbabu 37/M 8300 62 34 4 5 10 10.6 26 0.7 Nil Nil Nil 
36 8298 Mr.kumar 53/M 9600 55 42 3 3 7 10.6 30 0.9 Nil Nil Nil 
37 5597 Mr.venkatesan 58/M 8700 61 35 4 10 25 11.8 26 0.7 Nil Nil Nil 
38 6782 Mrs.tamilkodi 57/F 8500 65 32 3 2 5 11.2 26 0.7 Nil Nil Nil 
39 7074 Mrs.valli 52/F 7700 63 31 6 5 16 9.4 25 0.8 Nil Nil Nil 
40 7337 Mrs. Usha 58/F 8100 49 46 5 12 30 14.8 23 0.7 Nil Nil Nil 
 
 
TC – Total count, DC – Differential count, P – Polymorphs, L – Lymphocyte, E – Eosinophil, ESR – Erythrocyte Sedimentation Rate, 
Oec – Occasional epithelial cells, Opc – Occasional pus cells, Alb – Albumin, Sug – Sugar, Dep – Deposits 
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LABORATORY INVESTIGATION REPORT 
 
AFTER TREATMENT 
 
 
 
 
S.No 
 
 
OP.
No 
 
 
Name 
 
 
Age/Sex 
Haematological report RFT Urine Analysis 
 
TC 
cells/ 
cu.mm 
 
DC 
% 
   
ESR
mm 
 Hb 
gms
% 
 
Urea 
mg/dl 
 
Creatinine 
mg/dl 
 
Alb 
 
Sug 
 
Dep 
 P L E ½ hr 1 hr       
1 6126 Mr.kumar 35/M 9400 57 39 4 7 13 11 32 0.6 Nil Nil Opc 
2 6238 Mrs.Rajeswari 36/F 8400 54 42 4 6 15 10.2 31 1.0 Nil Nil Oec 
3 6243 Mr. Ilango 37/M 8000 57 39 4 5 15 12.6 34 0.9 Nil Nil Opc 
4 2516 Mrs.Lalitha 31/F 9300 52 45 3 12 25 11 29 1.0 + Nil Opc 
5 5986 Mr.Saravanan 32/M 8900 60 37 3 7 12 10.2 29 0.8 Nil Nil Oec 
6 2093 Mr. karuppaiya 40/M 9200 57 41 2 10 27 9.6 31 0.6 Nil Nil Nil 
7 8914 Mr.venkat 27/M 9200 60 36 4 10 26 11.9 29 0.9 Nil Nil Nil 
8 8923 Mr.saravanan 42/M 8800 61 35 4 6 15 10.2 24 1.0 Nil Nil Nil 
9 7981 Mr.chandran 46/M 8400 53 41 6 15 26 13.4 26 0.5 Nil Nil Opc 
10 8123 Mrs.Mahalakshmi 38/F 8900 51 43 6 17 30 12.8 28 0.7 Nil Nil Opc 
11 6823  Mr .John 42//M 8500 62 35 3 12 28 8.5 20 0.8 Nil Nil Opc 
12 8123 Mrs.suganya 36/F 9400 55 42 3 7 15 13 23 1.1 Nil Nil Oec 
13 7289 Mr.jabhar  31/M 9200 63 33 4 2 5 10.8 26 0.7 Nil Nil Oec 
14 8855 Mr.mahalingam 40/M 8500 58 37 5 5 12 9.6 29 0.7 Nil Nil Nil 
15 9900 Mrs.vimala 37/F 8700 49 46 5 22 40 10.2 28 0.9 Nil Nil Opc 
16 8110 Mr. mahendran 33/M 8000 58 39 3 4 10 13 21 0.7 Nil Nil Oec 
17 7263 Mr.sundar 38/M 8200 53 44 3 14 25 13 24 0.9 Nil Nil Oec 
18 7464 Mr. karuppasamy 35/M 8900 61 34 5 8 15 11.2 26 0.8 Nil Nil Oec 
19 7632 Mrs , kokila 35/F 8000 61 37 2 10 22 13 27 0.9 Nil Nil Opc 
20 7704 Mrs.Rani 55/F 9000 57 39 4 5 11 13 32 1.0 Nil Nil Opc 
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21 8002 Mr .manikandan 36/M 8600 58 39 3 10 15 13.6 36 1.1 Nil Nil Opc 
22 8223 Mr.tamilarasan 38/M 8700 62 35 3 6 12 12.8 24 0.8 Nil Nil Oec 
23 8863 Mrs .jayabharathi 55/F 9000 54 42 4 2 8 12 24 0.9 Nil Nil Nil 
24 1452 Mr.karthikeyan 34/M 8200 59 39 2 6 15 10.8 25 1.1 Nil Nil Opc 
25 4084 Mrs.Dhanalakshmi 42/F 10000 57 38 5 5 12 14.2 28 0.6 Nil Nil Nil 
26 6318 MrsGeethapandian 44/F 8600 65 32 3 2 5 13.4 22 0.7 Nil Nil  Nil 
27 7954 Mrs. Lalitha 48/F 8700 57 40 3 10 20 11.2 21 0.6 Nil Nil Nil 
28 2669 Mrs. Lalitha 31/F 9400 55 41 4 2 4 12.5 28 0.9 Nil Nil Opc 
29 629 Mr.mankandan 42/M 7600 55 42 3 3 7 13 25 0.7 Nil + Oec 
30 1613 Mr .arunkumar 31/M 9700 57 38 5 5 12 12 27 0.7 Nil Nil Oec 
31 2109 Mrs.valarmathi 28/F 8200 50 47 3 2 7 10.8 26 1.0 Nil +++ Opc 
32 1947 Mr. sreeramalu 48/M 8200 57 40 3 7 15 14.6 24 0.7 Nil Nil Oec 
33 3451 Mrs. Gowri 50/F 8300 60 37 3 15 35 14 28 0.9 + Nil Opc 
34 8163 Mr.gaanam 24/M 9900 71 25 4 5 12 13.7 - - Nil Nil Opc 
35 6430 Mr. Sathishbabu 37/M 9600 55 42 3 3 7 10.6 30 0.9 Nil Nil Oec 
36 8298 Mr.kumar 53/M 8600 61 35 4 10 25 11.8 25 0.6 Nil Nil Nil 
37 5597 Mr.venkatesan 58/M 8600 65 32 3 2 5 11.2 28 0.7 Nil Nil Nil 
38 6782 Mrs.tamilkodi 57/F 8400 66 29 5 22 40 12.2 - - Nil Nil Nil 
39 7074 Mrs.valli 52/F 7900 49 46 5 12 30 14.8 21 0.7 Nil Nil Opc 
40 7337 Mrs. Usha 58/F 9600 59 37 4 5 15 11.6 30 0.8 Nil Nil Opc 
 
TC – Total count, DC – Differential count, P – Polymorphs, L – Lymphocyte, E – Eosinophil, ESR – Erythrocyte Sedimentation Rate, 
Oec – Occasional epithelial cells, Opc – Occasional pus cells, Alb – Albumin, Sug – Sugar, Dep – Deposit 
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DISCUSSION 
KALLADAIPPU is a common disease pertaining to the kidney. Large 
populations are suffering from this disease. But they are not completely relieved from 
their symptoms by other systems of medicine. Hence with the help of trial medicine 
from Siddha system, results and observations are noted for this study. 
 The patients were examined base on Siddha and as well as modern aspects. All 
the necessary investigations were made during the study. The results obtained from 
their studies were discussed below for better conclusion. 
 Trial medicine administered was Karpoora silasathu parpam – 130 mg 2 times 
a day with Ilaneer after food for 48 days. 
40 cases were selected and admitted in the In
- 
patient ward of Arignar Anna 
Government Hospital of Indian Medicine attached to Government Siddha Medical 
College, Arumbakkam, Chennai – 106 during the period of  2014 – 2017.All necessary 
investications were carried out to all patients an 
Trail  drug were given. Daily follow up were done. All the patients were 
strictly advised to follow diet restriction and peaceful lifestyle to normalize the 
immune mechanism. 
My  trial drug was justified for Kalladaippu through various process Drug 
Authentication, Trial drug, IAEC, Toxicity study, Pharmacological Activity, 
Biochemical Analysis, Phsiochemical Analysis, IEC, CTRI, Clinical study, 
Biostatistic. 
DRUG AUTHETICATION: 
       I  have got a drug authentication of minerals like Karpoora silasathu, 
venkaram from Department of  Pharmacology and freshly specimens of Gossypium 
herbaceum ,Abutilon indicum  were collected from their nativity and got 
authentication from the botanist  Dept, of Medicinal Botany, Govt. Siddha Medical 
College, Arumbakkam, Chennai – 106. 
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PRE CLINICAL SCREENINGS: 
PHSIOCHEMICAL ANALYSIS: 
               Loss on Drying(at 105
0
C) was 5.37%, The total ash value of Karpoora 
silasathu parpam was 73.16%, The water soluble ash value was 32.19% The acid 
soluble ash value was 10.23%,  pH value was 8.56%. 
IAEC: 
               IAEC NO: SU/CLATR/IEAC/VII/050/2016. 
TOXICITY STUDY: 
ACUTE TOXICITY: 
               Acute and sub acute toxicity studies were conducted on experimental rats at 
Sathyabama University, Chennai, Tamilnadu. 
               Acute toxicity study of the drug Karpoora silasathu parpam with Ilaneer  was 
carried out as the OECD guideline -  423 (Organisation to Econamic Co-operation and 
Development). 
                The acute toxicity study of  my trial drug was studied and the drug was 
proved safer for long term administration, as it did not exhibit any significant toxicity 
at 2000 mg / kg body weight.  
SUB ACUTE TOXICITY: 
                 Sub acute toxicity study as per the guideline of – 407. Under the dosage of 
trial drug 200mg / kg (Low dose), 400mg / kg (High dose) it did not exhibit any 
significant.  
HISTO PATHOLOGY: 
                 At the end of toxicity studies the animal were sacrified and they were 
subjected to hematological parameters (TC, DC & Hb) chemical parameters ( LFT, 
RFT) and histopathology of vital organs like Liver, Kidney, Spleen, Lungs were 
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carried out. The studied did not exhibit the evidence of remarkable pathological 
lesions in the tissues. 
PHARMACOLOGICAL ACTIVITY: 
                 The pharmacology studies of trial medicine Karpoora silasathu parpam 
showed significant Anti Urolithiaticc action in wistar rats. 
                 The Anti Urolithiaticc activity of  Karpoora silasathu parpam was carried 
out in wistar rats through Ethylene Glycol-induced urolithiasis  method. Then trial 
drug was administrated shows a potent Anti Urolithiatic activity during the studies. 
                  The result of preclinical screening, the result of chemical analysis, 
Toxicological studies, Pharmacological studies were shown in anexures. 
BIOCHEMICAL ANALYSIS: 
                  Karpoora silasathu parpam contains, Calcium, Potassium, 
Chlorides, Phosphate. 
IEC, CTRI: 
Study Design 
           The study was approved by Institutional Ethics Committee ( IEC ) and the 
approval number is GSMC-CH-ME-4/2015/010.It was registered in Clinical Trials 
Registry – India ( CTRI ) and the reference number is CTRI/2017/04/008435. 
 
Population and sample : 
          The population consists of all patients satisfying the inclusion and exclusion 
criteria mentioned below. Sample consists of KALLADAIPPU patients who were 
attending the OPD of Arignar Anna Hospital, Arumbakkam, Chennai – 106. 
Sample Size : 
          The trial size will be 40 patients. 
CLINICAL STUDY: 
           All the necessary investigation were carried out to all patients and trial drug 
were given. Weekly once follow up were done. Total duration of treatment ranges 
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from 48 days. All the patients were strictly advised to follow diet restriction and 
peaceful life style to normalize the immune mechanism. 
GENDER DISTRIBUTION: 
        From selected 40 cases of  57.5% were males and 42.5% were females      
Urolithiasis  is most commonly affected in male. 
AGE DISTRIBUTION:  
          Out of  40 cases 21 patients (52.5%) were between  31 – 40 years, 9 patients 
(22.5%) were between 41 – 50 years, 7 patients (17.5%) were between 51 – 60 years 
and 3 patients (7.5%) were between 21-30 years. 
          High incidences of cases were noted in age ranging of 31 – 40 years during the 
studies.  The disease is more common in 3
rd 
and 4
th 
decade. 
SEASONAL INCIDENCE: 
         According to Paruva kaalam highest incidence of 37.5% were noted in 
Muthuvenir  kaalam and 20% cases were noted in Ilavenir  kaalam and 17.5% comes 
under Munpani kaalam , 15% of cases were noted in Koothir kaalam and 10% of cases 
were noted in Karaalam. 
         When clinical trial of  40 cases were enquired about the seasonal link, most of 
the cases were in Muthuvenir  Kaalam due to seasonal variation. 
OCCUPATIONAL STATUS: 
          From selected 40 cases, 14 patients (35%) were house wife, 11 patients 
(27.5%) were office workers,9 patients (22.5%) were coolies, 4 patients (25%) were 
business and 2 patients were (5%) students. 
         Mixed catagories of people are affected from housewife, workers. 
SOCIO ECONOMIC STATUS 
            Recording Socio Economic Status 24 patients (60%) were low income and 10 
cases (25%) from middle income and 6 cases (15%) from high income.  
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           The people living in poor Socio Economic Status were more affected because 
of life style and environmental factors. 
DIET REFERENCE: 
            Out of 40 cases, most of the cases 35 (87.5%) were taken mixed diet and 5 
cases (12.5%) had vegetarian diet only.  
THINAI DISTRIBUTION: 
                 According to the study, nearly 36 cases (90%) were from Neithal 
thinai,10% cases from marutham. 
CLINICAL MANIFESTATION: 
         In respect of the patients with Kalladaippu, the clinical manifestation of  Flank 
Pain were present in 40 cases (100%), Burning micturation had present in 18 cases 
(45%), Oliguria were present in 12 cases (30%),  Nausea were present in 6 cases 
(15%), Fever in 4 patients (10%) and Vomitting and Dysuria in 2 cases (5%). 
   
MUKKUTRAM: 
 
DISTRIBUTION OF VATHAM: 
           According to classification of Vatham, derangement of Abanan, 
Viyanan,Uthhanan and Devathathan. 40 patients (100%) was affected with Abanan, 40 
patients (100%) was affected with Viyanan,12 patients (30%) was affected 
withUthanan,11 patients (22.5%) was affected with Devathathan and none affected 
with Pranan, Samanan , kirukaran, Naagan ,korman and Thananjeyan. 
          Affected Abanan produced Burning micturition ,constipation and hematuria. 
 Affected Viyanan produced (pain) tenderness from loin to groin.  
        Affected Uthanan produced nausea and vomiting. 
 Affected Devathathan produced insomnia. 
 
                                                                                                             DISCUSSION 
 
Karpoora silasathu parpam for Kalladaippu Page 97 
 
DISTRIBUTION OF PITHAM: 
           According to Pitham 40 cases (100%) were affected  Saathgam , 9 cases 
(22.5%) was affected with Ranjagam. 
           All the cases were unable to carryout regular works properly. Sathagam 
indicates this one. So 100% were affected in Sathaga pitham. 
          Affected Ranjagam produced pallor of skin, eye and reduced hemoglobin. 
DISTTRIBUTION OF KABAM: 
        According to the study, 12 cases (30%) affected by Santhigam, 
         Santhigam iyam gives stability, lubrication and movements of joints. 
         Affected Santhigam produced low back pain. 
EZHU UDAL KATTUGAL: 
         From the above chart, we observe that Saaram, were affected in all the patients 
(100%),Senneer was affected in 9cases (22.5%), Enbu was affected in 12 cases (30%), 
None affected with Oon,Kozhupu,Moolai and Sukkilam / Suronitham. 
ENVAGAI THERVUGAL: 
        According to Envagai thervugal,Niram was affected in 9 patients (22.5), Vizhi 
was affected in 4 patients (10%), Sparisam was affected in 7 patients (17.5%), Malam 
was affected in 1 patient (2.5%), Naadi was affected in for all the 40 patients. 
        Niram were affected due to anaemia (pale colour). 
        In Vizhi were affected had dullness of vision. 
        Mozhi were affected low pitched sound. 
        Sparisam were affected due to tenderness pain. 
        In Malam were affected due to constipation. 
        Naadi was affected in all patients. 
NAADI 
       Out of 40 patients, 24 patients (60%) had Vatha Azhal, 11 patients (27.5%) had 
Azhal Vali, 3 patient (7.5%) Kabha Pitham, 2 patient (5%) Kabha Vatham.    
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    NEIKURI : 
        Out of  40 patients (62.5%) had Pitha Neer, 11 patients (27.5%) had Vatha Neer 
and 4 patients (10%)had Kabha Neer. 
CLINICAL PROGNOSIS: 
         The clinical signs and symptoms were improved after treatment,showing only 5 
cases (12.5%) had Flank pain, 2 cases (5%) had Burning micturation. 
IMPROVEMENT:  
            Among the total 40 patients all were improved both subjectively and 
objectively. 
            Clinical symptoms before and after treatment were noted. To obtain prognosis 
of each clinical symptom, the following formulae was used 
 
 
 
 
                Thus the clinical trial study showed significant clinical improvement in 
certain clinical manifestation of  Kalladaippu such as Flank pain were present in all 
cases. Burning micturation were present in 18 cases (45%), Oliguria had present in 12 
cases (30%), Nausea were present in 6 cases (10%),  Fever were present in 4 cases 
(10%), Vomiting in 2 patients (5%) and Dysuria in 2 cases (5%). 
 
INVESTICATION:  
                In Blood tests, TC, DC, ESR, Hb% serum creatinine, blood urea were 
investigated. 
URINE: 
     Albumin, Sugar, Deposit were investigated. 
 
 
 
             No. Of cases after treatment      ×100 
           No. of cases before treatment 
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SPECIAL INVESTICATION: 
USG- abdomen and pelvis is advised for all the patients to confirm the 
diagnosis. 
After confirming the diagnosis, the patients were given the trial 
medicine and instructed to follow the diet and other restrictions based on 
Siddha system. 
BIO STATISTICAL STUDY: 
             Since the p value C.I: 95%,  *P<0.05; **P<0.01 is significant in all clinical 
manifestations. So there is significant reducing of clinical manifestations among the 
patients for the treatment of  Kalladaippu. Hence it is concluded that the treatment was 
effective and significant. 
DISTRIBUTION OF CALCULI BASED ON LOCATION : 
         Since the p value C.I: 95%,  *P<0.05; **P<0.01 is significant in all sides. So there 
is significant changes grades of pain among the patients for the treatment of  
Kalladaippu. Hence it is concluded that the treatment was effective and significant.   
 
OVER ALL RESULT: 
Out of 40 patients, 17 cases (42.5%) shows good result, 19 cases (47.5%) shows 
moderate result, 4 cases (10%) shows poor result. 
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SUMMARY 
           The clinical study on Kalladaippu was carried out in Post graduate department 
of Pothu Maruthuvam, Government Siddha Medical College, Aringar Anna Hospital, 
Chennai – 106 during the period of 2015-2017. 
A total of 40 patients were treated in the Outpatient department. The clinical 
and pathological assessment was carried out on the basis of Siddha and Modern 
aspects. 
All the patients were treated with Karpoora silasathu parpam with Ilaneer 
130 mg b.d daily, after food for duration of 48days. 
 males were mostly affected (57.5%). 
 Most of the patients were in the age group between 31-40 years (52.5%) 
 Most of the patients were from Neithal Thinai (82.5%). 
 In this study, most of the cases (35%) were house wives. 
 Most of the patients were affected in Muthuvenirkaalam (37.5%). 
 In Vali, Abanan (100%), Viyanan (100%), Uthanan (30%), and Devadhathan 
(27.5%) was affected. 
 In Azhal, Saathagam (100%), Ranjagam (22.5%) was affected. 
 In Iyyam, Santhigam (30%) was affected. 
 In Ezhu udal kattugal, Saaram (100%), Seneer (22.5%) and Enbu (30%) was 
affected. 
 Regarding naadi, (60%) had Vatha Azhal was the most common naadi 
observed. 
 The Toxicological studies of the trial medicine reveal no toxicity. 
 The Pharmacological studies reveal that, the trial drug has Anti Urolithiatic 
activity. 
 Bio- statistical analysis of the clinical trial reveals significant p value < 0.05 
and ˂ 0.01 and concluded that the treatment is effective and significant. 
Regarding grading of the result, 17 cases (42.5%) shows good improvement, 19 cases 
(47.5%) shows moderate  improvement, 4 cases (10%) shows poor improvement. 
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CONCLUSION 
 
 Kalladaippu is a common disorder of pitha kutram. The dearranged pitham is 
settled down by the ingredients of trial medicine having astringent taste 
thereby the medicine acts as ethirurai maruthuvam to cure the disease. 
 Most of the cases noted in muthuvenir kalam and elavenir kalam in my clinical 
trial. So, people should take all preventive measures during this period and take 
enough water. 
 Toxicological study shows no acute and sub - acute toxicity. 
 Pharmacological study reveals that the trial medicines possess Anti Urolithiatic 
activity. 
 During clinical trial, no adverse reactions or complications were observed. 
 The trial medicine Karpoora silasathu parpam showed good results with 
relieving symptoms in almost 90% patients. 
 Once again Siddha medicine proves itself as a great boon to mankind. 
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ACUTE AND REPEATED 28 DAYS ORAL TOXICITY STUDY ON 
KARPOORA SILASATHU PARPAM 
ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Karpoora  Silasathu Parpam was 
carried out as per OECD guideline (Organization for Economic Co-operation and 
Development) Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
       Acute toxicity study will be carried out in accordance with OECD guideline 423 
77. The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Karpoora Silasathu Parpam.  
IAEC SU/CLATR/IAEC/IV/014/2016 
Animal Grouping 
One group consist of 6 female rats were used for this study . The dose utilized 
for evaluation of acute toxicity study is about 2000 mg/kg higher than that of the 
therapeutic dose.  
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Karpoora Silasathu 
Parpam 2000mg/kg (p.o). The animals were observed continuously for first 72 h and 
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then 14 days for emerging signs of behavioral changes, body weight changes and for 
mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention.   
Body weight was recorded periodically. At the end of the experiment all 
animals were subjected for gross necropsy and observed for pathological changes. 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-
407 
78
. 
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC SU/CLATR/IAEC/IV/014/2016 
 
Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male 
and 3 female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
GROUP II : Animals received low dose of test drug 200 mg/kg (p.o) 
GROUP III : Animals received high dose of test drug 400 mg/kg (p.o) 
The animals were randomly divided into control group and drug treated groups 
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for two different doses viz. low dose (200 mg/kg b.w) and high dose (400 mg/kg b.w). 
The animals were administrated with the study drug once daily for 28 days. 
The animals in group I (control group) received normal saline 5 ml/kg b.w. The 
animals in group II received low dose of Karpoora Silasathu Parpam 200 mg/kg b.w 
(p.o) and group III received high dose of Karpoora Silasathu Parpam 400 mg/kg b.w 
(p.o). 
The rats were weighed periodically and observed for signs of toxicity pertains 
to C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and 
morphological changes. At the end of 28th day, the animals were fasted for overnight 
with free access to water. On 29th day the animals were sacrificed with excess 
anesthesia. Blood samples were collected from aorta and stored in EDTA 
(ethylenediamine –tetra actate) for Hematological analysis and for serum generation 
for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
 
Hematological analysis 
Blood samples were analyzed using established procedures and automated 
Bayer Hematology analyzer. Parameters evaluated include Packed Cell Volume 
(PCV), Red Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Hemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil’s, Basophils, Lymphocytes and Monocytes. 
  
Biochemical analysis 
79
  
Serum samples were analyzed for High Density Lipoprotein (HDL), Low 
density Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides 
(TGL), Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total 
Protein, Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino 
Transaminase (ALT) and Alkaline  Phosphatase (ALP) using Mind ray auto analyzer 
model BS 120. 
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Histopathological evaluation 
80
 
 Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes 
and ovary. Histological slides of organs were made and observed under the 
microscope.  The pathological observations of cross section of these organs were 
performed on gross and microscopic bases. Histological examinations were performed 
on the preserved tissues with particular emphasis on those which showed gross 
pathological changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD 
PRISM 5 computer program). Results were expressed as mean ± standard error .A 
statistical comparison was carried out using the Dunnet’s test for the control and 
treatment group.  
Fecal Pellet Analysis 
Methodology 
Rats of control and treatment group were allowed to explore to open field on clean and 
sterile Stainless steel tray. The collected pellets were analyzed for consistency, color, 
Shape, Presence of blood cells etc 
Acute Toxicity Study 
Analysis Group I 
Consistency Soft 
Shape Pointed Head 
Colour Greenish 
Mucous Shedding 
Absence 
Blood Cells Absent 
Signs of Infection None Observed 
 
Sub-Acute Toxicity Study 
Analysis Group I Group II Group III 
Consistency Soft Soft Soft 
Shape Oblong Pointed Head Pointed Head 
Colour Brownish green Greenish Greenish 
Mucous Shedding Absence Absence Absence 
Blood Cells Absent Absent Absent 
Signs of Infection None Observed None Observed None Observed 
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Muscle Grip Strength Analysis 
The grip strength test is a simple non-invasive method designed to evaluate rat muscle force in 
vivo. Rats of control and drug treated group was allowed to hold the pull bar with both the 
hind limbs firmly then the animal was gently pulled back with the tail until the animal lost the 
grip toward the bar. The procedure was repeated to get the average value. Muscle grip ness of 
the drug treated group was compared to that of the control rat to ensure the change in 
coordination.  
Metabolic Cage for Urine Collection 
Rat of control and treatment group was placed individually in metabolic cage with free 
access to feed and water. Urine dropping from the animal was collected using 
specialized wire mesh system fixed at the base of the cage having provision to trap the 
fecal pellet mixed with urine sample. The collected urine sample was subjected to 
analysis with respect to colour, pH, glucose, ketone bodies, pus and blood cells. 
 RESULTS 
Assessment of clinical signs in rats treated with Karpoora  Silasathu Parpam on 
Acute toxicity study 
Parameter Group I 
Clinical Signs Parameters for the 
duration of 14 days 
Test Drug 2000  
mg/ Kg    
Number of animals observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Absence 
Touch Response Normal 
Response to Sound Normal Response 
Response to Light Normal Response 
Mobility Normal Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behavior Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behavior Normal 
Gait Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and Anxiety None Observed 
Muscular coordination Normal 
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Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis No Abnormality 
Urine Colour Yellowish 
Urine pH 6 
Urine -Glucose                         Absence 
Urine -Ketones                        Absence 
Urine- Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
 
Quantitative data on the body weight of rats treated with Karpoora  Silasathu 
Parpam in Acute toxicity study 
Group I Before Treatment After Treatment 
Mean 
189.8 193 
Std. Deviation 
4.309 3.578 
Std. Error 
1.759 1.461 
 
Values are mean ± S.D (n = 6 per group). Control and treatment group were compared 
statistically using one way ANOVA followed by Dunnett’s test. 
Assessment of clinical signs in rats treated with Karpoora  Silasathu Parpam on 
Sub-Acute toxicity study 
 
 
Parameter Group I Group II Group III 
Clinical Signs Parameters 
for the duration of 28 
days Control 
Test Drug 
200mg/ Kg    
Test Drug 
400mg/ Kg    
Number of animals 
observed 
3 Male and 3 
Female 
3 Male and 
3 Female 
3 Male and 
3 Female 
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
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Absence Absence Absence Absence 
Touch Response Normal Normal Normal 
Response to Sound 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Response to Light 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Mobility Normal Normal Normal 
Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behavior Absence Absence Absence 
Piloerection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behavior Normal Normal Normal 
Gait Balancing Normal Normal Normal 
Freezing Behavior Absent Absent Absent 
Sings of Stress and 
Anxiety None Observed 
None 
Observed 
None 
Observed 
Muscular coordination Normal Normal Normal 
Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behavior Normal Normal Normal 
Urine Analysis No Abnormality 
No 
Abnormality 
No 
Abnormality 
Urine Colour Yellowish Yellowish Yellowish 
Urine pH 7 7 7 
Urine -
Glucose                         Absence Absence Absence 
Urine -
Ketones                        Absence Absence Absence 
Urine- 
Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
 
Effect of Karpoora  Silasathu Parpam on Body weight of Rats in Sub-acute 
toxicity study 
Group I Before Treatment Weight in Gms 
After Treatment Weight in 
Gms 
Mean 
184.2 186.5 
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Std. Deviation 
5.981 5.891 
Std. Error 
2.442 2.405 
Group II Before Treatment Weight in Gms 
After Treatment Weight in 
Gms 
Mean 
179.3 187.2 
Std. Deviation 
8.066 7.885 
Std. Error 
3.293 3.219 
Group III Before Treatment 
After Treatment Weight in 
Gms 
Mean 
180.7 191.2 
Std. Deviation 
3.67 4.167 
Std. Error 
1.498 1.701 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Quantitative data on the food and water intake of rats treated with Karpoora  
Silasathu Parpam for 28 days in Sub-acute toxicity study 
Group I Food intake Water intake 
Mean 16.08 20.42 
Std. Deviation 2.47 5.984 
Std. Error 1.235 2.992 
      
Group II Food intake Water intake 
Mean 15.25 28.42 
Std. Deviation 1.549 0.3191 
Std. Error 0.7743 0.1596 
Group III Food intake Water intake 
Mean 13.67 27.75 
Std. Deviation 1.333 1.424 
Std. Error 0.6667 0.712 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Karpoora  Silasathu Parpam on Haematology profile of rats in sub-acute 
toxicity study. 
Group I 
 WBC 
count 
(×103 
µl) 
RBC 
(×10 6 
µl) 
PLT 
(×10 3 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 7.983 5.683 506.2 56.35 17.98 31.78 12.04 
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Std. 
Deviation 2.408 0.9347 311.2 4.615 2.771 2.477 2.252 
Std. Error 0.983 0.3816 127 1.884 1.131 1.011 0.919 
                
Group II 
 WBC 
count 
(×103 
µl) 
RBC 
(×10 6 
µl) 
PLT 
(×10 3 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 11.08 7.05 925.7 60.5 17.32 30.9 13.24 
Std. 
Deviation 3.293 1.046 233.9 6.637 2.022 1.462 2.314 
Std. Error 1.344 0.4272 95.47 2.71 0.8256 0.5967 0.945 
Group III 
 WBC 
count 
(×103 
µl) 
RBC 
(×10 6 
µl) 
PLT 
(×10 3 
µl) 
MCV     
(fl) 
MCH    
(pg) 
MCHC 
(g/dl) 
HGB 
(g/dl) 
Mean 9.567 6.833 672.2 60.17 18.92 31.43 12.45 
Std. 
Deviation 1.527 1.305 302.1 6.156 3.484 1.48 2.109 
Std. Error 0.6233 0.5327 123.3 2.513 1.423 0.6042 0.861 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Karpoora  Silasathu Parpam on Haematology profile of rats in sub-acute 
toxicity study. 
Group I 
Lymph        
(%) 
Mon            
(%) 
Neutrophil 
(X10
3
/mm3) 
Eosinophils (%) Basophils (%) 
MPV(fl) 
Mean 75.23 2.4 2.1 1.217 0.3333 5.2 
Std. 
Deviation 10.23 1.255 0.4 0.3061 0.5164 1.664 
Std. Error 4.175 0.5125 0.1633 0.1249 0.2108 0.6792 
Group II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils10
3/mm3 
Eosinophils (%) Basophils (%) 
MPV(fl) 
Mean 74.65 4.1 2.267 1.35 0.5 5.733 
Std. 
Deviation 7.701 0.8899 0.6314 0.2739 0.5477 1.129 
Std. Error 3.144 0.3633 0.2578 0.1118 0.2236 0.4609 
Group III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils10
3/mm3 
Eosinophils (%) Basophils (%) 
MPV(fl) 
Mean 72 2.25 2.333 1.267 0.3333 5.283 
Std. 
Deviation 9.595 1.203 0.4131 0.2805 0.5164 1.367 
Std. Error 3.917 0.4911 0.1687 0.1145 0.2108 0.5582 
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Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Karpoora  Silasathu Parpam on Serum Bio-chemistry profile of rats in 
sub-acute toxicity study 
Group I 
Blood 
sugar 
® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum 
total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
choleste
rol 
(mg/dl) 
Mean 67.17 14.33 0.4333 110.3 79.5 49.17 35.5 12.98 
Std. 
Deviation 7.167 4.457 0.08165 22.6 16.26 7.96 17.42 3.277 
Std. Error 2.926 1.82 0.03333 9.226 6.637 3.25 7.112 1.338 
                  
Group II 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
choleste
rol 
(mg/dl) 
Mean 90.83 15.67 0.6167 125 71.33 54.33 36.83 19.13 
Std. 
Deviation 9.867 1.966 0.2563 7.266 10.48 13.57 12.69 3.267 
Std. Error 4.028 0.8028 0.1046 2.966 4.279 5.542 5.18 1.334 
Group 
III 
Blood 
sugar ® 
(mg/dl) 
BUN 
(mg/dl) 
 Serum 
creatinine 
(mg/dl) 
Serum total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholesterol 
(mg/dl) 
Serum 
LDL 
cholesterol 
(mg/dl) 
Serum 
VLDL 
choleste
rol 
(mg/dl) 
Mean 74.33 15.67 0.6667 103.3 86.83 62.17 42.67 18.63 
Std. 
Deviation 12.77 5.046 0.2582 18.39 9.786 11.02 12.82 2.67 
Std. Error 5.213 2.06 0.1054 7.509 3.995 4.498 5.232 1.09 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Effect of Karpoora  Silasathu Parpam on Serum Bio-chemistry profile of  rats in 
sub-acute toxicity study 
Group I 
Serum total 
protein (g/dl) 
Serum albumin 
(g/dl) (AST)  
(IU/ml) 
(ALT) 
(IU/L) 
(ALP) 
(IU/L) 
Mean 3.633 2.917 131.2 31.83 155.3 
Std. Deviation 0.9668 0.5345 8.256 9.02 74.81 
Std. Error 0.3947 0.2182 3.371 3.683 30.54 
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Group II 
Serum total 
protein (g/dl) 
Serum albumin 
(g/dl) (AST)  
(IU/ml) (ALT) (IU/L) 
(ALP) 
(IU/L) 
Mean 5.9 3.75 108 37.33 135.2 
Std. Deviation 1.11 0.5753 28.59 7.866 14.66 
Std. Error 0.4531 0.2349 11.67 3.211 5.986 
Group III 
Serum total 
protein (g/dl) 
Serum albumin 
(g/dl) (AST)  
(IU/ml) (ALT) (IU/L) 
(ALP) 
(IU/L) 
Mean 5.067 2.967 117.3 29 114 
Std. Deviation 1.451 0.9288 24.94 6.325 24.09 
Std. Error 0.5925 0.3792 10.18 2.582 9.835 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett’s test. 
Quantitative data on absolute organ weight of rats treated with Karpoora  
Silasathu Parpam for 28 days in Sub-acute toxicity study. 
Group I 
HEART 
(gms) 
 LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
Uterus 
and 
Ovary 
(gms) 
Mean 0.54 4.672 1.283 0.55 1.383 1.317 1.233 2.7 1.333 
Std. 
Deviation 0.1534 0.7039 0.1236 0.2588 0.2229 0.1941 0.2251 0.6083 0.1528 
Std. Error 0.06261 0.2874 0.05044 0.1057 0.09098 0.07923 0.09189 0.3512 0.08819 
Group II 
HEART 
(gms) 
 LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
Uterus 
and 
Ovary 
(gms) 
Mean 0.5917 5.843 1.51 0.5167 1.483 1.517 1.4 4.133 1.167 
Std. 
Deviation 0.1439 1.002 0.2059 0.1722 0.2137 0.2994 0.4147 0.3786 0.3512 
Std. Error 0.05873 0.4091 0.08406 0.07032 0.08724 0.1222 0.1693 0.2186 0.2028 
Group 
III 
HEART 
(gms) 
 LIVER 
(gms) 
KIDNEYS 
(gms) 
SPLEEN 
(gms) 
BRAIN   
(gms) 
LUNG    
(gms) 
STOMACH               
(gms) 
TESTES 
(gms) 
Uterus 
and 
Ovary 
(gms) 
Mean 0.7883 5.653 1.348 0.6167 1.517 1.583 1.467 2.1 1.067 
Std. 
Deviation 0.1401 0.5721 0.205 0.2137 0.1835 0.1472 0.4885 0.7 0.3215 
Std. Error 0.05718 0.2335 0.08368 0.08724 0.07491 0.06009 0.1994 0.4041 0.1856 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for Heart, 
Liver, Kidney, Brain, Spleen, Lung, Stomach.   Values are mean ± S.D (n = 3 per 
group per sex ) for testes , ovary and uterus for Control and treatment groups were 
compared statistically using one way ANOVA followed by Dunnett’s test. 
 
                                                                                                            TOXICITY STUDY                   
Karpoora silasathu parpam for Kalladaippu Page 117 
 
HISTOPATHOLOGY REPORT 
BRAIN  
Histology of brain revealed the presence of normal cortex showing neurons, 
glial cells and capillaries. Section of cerebellum shows distinct molecular and granular 
layer. Neuronal architecture appears normal with sufficient numbers. No signs of 
ischemia or lesion were observed in sample belongs to group I,II and III. 
HEART  
Appearance of fibrils and cross striations are equidistant. Sarcoplasmic region 
of myocardium appears normal. Appearance of cardiomyocyte was normal with dark 
nuclear region. The nuclei of muscle fibers appear oval arrangement were observed in 
samples belongs to group I, II and III. 
LUNG 
Perivascular region appears normal, Alveolar septa and wall appeared widen 
and normal. No signs of airway secretion and bronchial secretion. Bronchial blood 
vessels and connective tissue appears normal with no sings of pulmonary edema in 
control and treatment group rats. 
LIVER 2 
The walls of the lumen appears normal with no evidence of  ischemic changes 
.No evidence of infiltration were observed in sample belongs to group I, II and III. 
STOMACH  
Microscopic analysis of stomach sample reveals normal anatomy of muscular 
stomach with epithelial layer keratinized stratified squamous epithelium, Lamina 
propria and Sub-mucosa were observed in sample belongs to group I, II and III. 
KIDNEY  
Appearance of glomerular basement membrane was normal. Lumen of distal 
convolutes tubule and collecting duct was normal in sample belongs to group I,II and 
III. 
SPLEEN  
Appearance of central artery and marginal sinus are normal. Erythropoietic 
cells (EP) are scattered throughout the red pulp of both the samples. No abnormalities 
found in lymph nodes were observed in sample belongs to group I, II and III. 
 
TESTES  
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Presence of mature somatic cells project the perfect histomorphology of 
testicular cells in this group. Primary spermatocytes with large centered nucleus and 
dense chromatin were observed in sample belongs to group I,II and III. 
UTERUS 
Appearance of endometrium, myometrium and uterine glands was normal. 
Arrangement of stratum basale, functionale and surface epithelium seems normal in 
sampls belongs to group I,II and III. 
OVARY  
Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality. 
Appearance of antral follicle, primary oocyte and secondary follicles are normal in 
sample belong to group I,II and III. 
 
Histopathology of Brain (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I           GROUP II   GROUP III 
 
High Power Magnification 40X 
     
GROUP I           GROUP II   GROUP III 
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Histopathology of Heart (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
          GROUP I          GROUP II    GROUP III 
High Power Magnification 40X 
      
         GROUP I          GROUP II     GROUP III 
Histopathology of Kidney (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
          GROUP I           GROUP II           GROUP III 
High Power Magnification 40X 
     
          GROUP I          GROUP II                GROUP III 
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Histopathology of Liver (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
      
GROUP I          GROUP II     GROUP III 
High Power Magnification 40X 
       
GROUP I          GROUP II    GROUP III 
Histopathology of Lung (Male Rat) in Sub-acute toxicity Study 
         Low Power Magnification 10X 
 
      
GROUP I   GROUP II    GROUP III 
High Power Magnification 40X 
              
 
 
 
 
GROUP I `  GROUP II       GROUP III 
                                                                                                            TOXICITY STUDY                   
Karpoora silasathu parpam for Kalladaippu Page 121 
 
Histopathology of Spleen (Male Rat) in Sub-acute toxicity Study 
 Low Power Magnification 10X 
 
 
 
 
 
   GROUP I            GROUP II `        GROUP III 
High Power Magnification 40X 
GROUP I          GROUP II      GROUP III 
Histopathology of Stomach (Male Rat) in Sub-acute toxicity Study 
     GROUP I          GROUP II               GROUP III 
High Power Magnification 40X 
    GROUP I       GROUP II    GROUP III 
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Histopathology of Testes (Male Rat) in Sub-acute toxicity Study 
          
 
 
 
 
GROUP I          GROUP II  GROUP III 
High Power Magnification 40X 
     
GROUP I          GROUP II        GROUP III 
Histopathology of Brain (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
                         
GROUP I          GROUP II   GROUP III 
High Power Magnification 40X 
                             
GROUP I   GROUP II   GROUP III 
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Histopathology of Heart (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I          GROUP II   GROUP III 
High Power Magnification 40X 
   
GROUP I          GROUP II      GROUP III 
Histopathology of Kidney (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
   
GROUP I          GROUP II     GROUP III 
High Power Magnification 40X 
   
GROUP I          GROUP II   GROUP III 
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Histopathology of Liver (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
   
GROUP I           GROUP II     GROUP III 
High Power Magnification 40X 
   
GROUP I          GROUP II   GROUP III 
Histopathology of Lung (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
     
GROUP I           GROUP II   GROUP III 
High Power Magnification 40X 
    
GROUP I          GROUP II    GROUP III 
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Histopathology of Spleen (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
   
GROUP I           GROUP II   GROUP III 
High Power Magnification 40X 
    
GROUP I           GROUP II    GROUP III 
Histopathology of Stomach (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
    
GROUP I           GROUP II    GROUP III 
 
      
GROUP I           GROUP II    GROUP III 
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Histopathology of Uterus (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
        
GROUP I           GROUP II    GROUP III 
High Power Magnification 40X 
       
GROUP I           GROUP II   GROUP III 
Histopathology of Ovary (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
        
GROUP I           GROUP II   GROUP III 
High Power Magnification 40X 
        
GROUP I           GROUP II   GROUP III 
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ANTI UROLITHIATIC ACTIVITY OF KARPOORA SILASATHU PARPAM 
(KSP) 
IN ETHYLENE GLYCOL INDUCED LITHIATIC RATS 
Animals 
Healthy adult Wistar albino male rats weighing between 200-220 g were used 
for the study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit . A 12 light / dark cycle were 
maintained .Room temperature was maintained between 22 + 2
o 
C
 
and relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study.The experimental protocol was approved by The Institutional 
Animal Ethics Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
IAEC: SU/CLATR/IEAC/VII/050/2016 
Experimental Methodology 
The animals were grouped into four groups of 6 animals each. Group I 
(Control group) -received normal saline, Group II – Urolithiatic control received EG 
(0.75% w/v, p.o.) in drinking water for 28 days ad libitum (Day1 and Day 28). Group 
III - Received EG (0.75% w/v, p.o.) in drinking water and treated with 200mg/kg of 
Karpoora Silasathu Parpam for the period of 28 days. Group IV Received EG (0.75% 
w/v, p.o.) in drinking water and treated with 400mg/kg of Karpoora Silasathu Parpam 
for the period of 28 days. 
Sample Collection 
At the end of the study, before sacrifice, the animals were fasted for overnight 
with free access to water. Animals were sacrificed with excess anesthesia. Blood 
samples were collected from retro orbital sinus puncture and stored in EDTA 
(ethylenediamine –tetra acetate) test tubes for Hematological analysis and in clot 
activator coated test tubes for serum biochemical analysis. Kidney sample were 
harvested and carefully investigated for gross lesions. The organ (kidney) were 
preserved in 10% formalin for histopathological assessment. 
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Urine Sample Analysis 
Urine samples (24 h) will be collected on the 28th day by keeping the animals 
in an individual metabolic cage. The animal had free access to drinking water during 
urine collection period.  
Parameters 
The parameters such as serum magnesium, calcium, Phosphate, uric acid and 
urine biochemistry such as BUN, pH, uric acid and Creatinine was estimated. 
 
 
The CaOX crystals viewed in light microscope in urine 
      Control Group                Ethylene Glycol-induced 
                                     
 
KSP 200 mg/kg                                         KSP400mg/kg 
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Effect of KSP on Urine output and pH of EG Induced urolithiatic rats 
GROUP I 
Urine Out put (ml/ 24 hr) 
Ph 
Mean 7.633 6.117 
Std. Deviation 0.4033 0.1602 
Std. Error 0.1647 0.0654 
GROUP II 
Urine Out put (ml/ 24 hr) 
pH 
Mean 11 7.433 
Std. Deviation 1.045 0.3011 
Std. Error 0.4266 0.1229 
GROUP III 
Urine Out put (ml/ 24 hr) 
pH 
Mean 15.27 6.4 
Std. Deviation 0.3882 0.2898 
Std. Error 0.1585 0.1183 
GROUP IV 
Urine Out put (ml/ 24 hr) 
pH 
Mean 20.07 6.333 
Std. Deviation 1.181 0.2944 
Std. Error 0.4821 0.1202 
 
Values are mean ± S.D / S.E (n = 6 per group) 
 
Effect of KSP on kidney weight of EG Induced urolithiatic rats 
GROUP I 
Kidney weight (gms) 
Mean 1.3 
Std. Deviation 0.1265 
Std. Error 0.05164 
GROUP II 
Kidney weight (gms) 
Mean 2.433 
Std. Deviation 0.1366 
Std. Error 0.05578 
GROUP III 
Kidney weight (gms) 
Mean 1.7 
Std. Deviation 0.08944 
Std. Error 0.03651 
GROUP IV 
Kidney weight (gms) 
Mean 1.55 
Std. Deviation 0.1378 
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Std. Error 0.05627 
Values are mean ± S.D / S.E (n = 6 per group) 
Effect of KSP on Serum biochemistry of EG Induced urolithiatic rats 
GROUP I 
Blood urea nitrogen (BUN) Creatinine  (mg/dl) 
Uric acid 
(mg/dl) 
Mean 37.17 0.5833 3.833 
Std. Deviation 3.971 0.2137 0.5164 
Std. Error 1.621 0.08724 0.2108 
GROUP II 
Blood urea nitrogen (BUN) Creatinine  (mg/dl) 
Uric acid 
(mg/dl) 
Mean 64 1.283 8.667 
Std. Deviation 3.521 0.2229 0.4633 
Std. Error 1.438 0.09098 0.1892 
GROUP III 
Blood urea nitrogen (BUN) Creatinine  (mg/dl) 
Uric acid 
(mg/dl) 
Mean 53.33 0.8333 4.85 
Std. Deviation 2.503 0.1966 0.295 
Std. Error 1.022 0.08028 0.1204 
GROUP IV 
Blood urea nitrogen (BUN) Creatinine  (mg/dl) 
Uric acid 
(mg/dl) 
Mean 45.17 0.4833 4 
Std. Deviation 3.189 0.07528 0.2608 
Std. Error 1.302 0.03073 0.1065 
 
Values are mean ± S.D / S.E (n = 6 per group) 
 
Effect of KSP on Urine Biochemistry of EG Induced urolithiatic rats 
GROUP I 
Magnesium 
(mg/dl/24hr) 
Calcium  
(mg/dl/24hr) 
Phosphate 
(mg/dl/24hr) 
Uric acid 
(mg/dl/24hr) 
Mean 4.567 5.5 34.33 8.283 
Std. Deviation 0.5279 0.429 3.67 0.3371 
Std. Error 0.2155 0.1751 1.498 0.1376 
GROUP II 
Magnesium 
(mg/dl/24hr) 
Calcium  
(mg/dl/24hr) 
Phosphate 
(mg/dl/24hr) 
Uric acid 
(mg/dl/24hr) 
Mean 9.065 25.18 76 15.83 
Std. Deviation 0.05244 1.466 2.53 0.5164 
Std. Error 0.02141 0.5986 1.033 0.2108 
GROUP III 
Magnesium 
(mg/dl/24hr) 
Calcium  
(mg/dl/24hr) 
Phosphate 
(mg/dl/24hr) 
Uric acid 
(mg/dl/24hr) 
Mean 6.783 19.73 42.33 12.33 
Std. Deviation 0.2317 2.088 2.422 1.033 
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Std. Error 0.09458 0.8523 0.9888 0.4216 
GROUP IV 
Magnesium 
(mg/dl/24hr) 
Calcium  
(mg/dl/24hr) 
Phosphate 
(mg/dl/24hr) 
Uric acid 
(mg/dl/24hr) 
Mean 5.2 14.23 38.17 10.17 
Std. Deviation 0.2366 0.3724 2.927 1.169 
Std. Error 0.09661 0.152 1.195 0.4773 
 
Values are mean ± S.D / S.E (n = 6 per group) 
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Histopathology of Rat Kidney (H&E) Staining 
Low Power Magnification 10 X 
Control Group                 EG treated Rat 
                 
 
 
 
KSP 200mg/kg      KSP 400mg/kg 
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Histopathology of Rat Kidney (H&E) Staining 
High Power Magnification 40 X 
 Control Group     EG treated Rat 
 
          
 
KSP 200mg/kg      KSP 400mg/kg 
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Pathology report 
 Normal glomerulus (G) surrounded by a narrow capsular space and the parietal 
layer of Bowman's capsule. Epithelial lining on proximal convoluted tubule 
appears normal. Lumen of distal convolutes tubule and collecting duct was 
normal 
 Ethyl glycol treated group reveals marked tubular dilatation, glomerular 
degeneration and increased crystal deposition. 
 Mild derangement in mesenchymal density along with reduced crystal 
deposition was observed in sample belongs to KSP 200mg/kg and 400 mg/kg 
treated rats. Accumulation of calcium oxalate deposits inside the tubules was 
much controlled in treatment group when compare to EG alone treated group. 
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
 
       Preparation of Sodium Carbonate extract: 
 
     2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken in a 
100 ml beaker and 20 ml of distilled water is  added. The solution is boiled for 10 
minutes, cooled and then filtered. The filtrate is called sodium carbonate extract. 
   
 
S.No EXPERIMENT OBSERVATION INFERENCE 
I                                    TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared 
extract is taken in a test tube. To 
this add 2ml of 4% Ammonium 
oxalate solution. 
Absence of 
White Precipitate 
Absent 
B 2ml of extract is added with 2ml 
of dilute hydrochloric acid until 
the effervescence ceases off. 
Then 2ml barium chloride 
solution is added. 
Absence of 
White Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with 
dilute nitric acid till the 
effervescence ceases. Then 2ml 
of silver nitrate solution is 
added. 
white precipitate not 
obtained 
Absent 
3 Test for Phosphate 
2ml of the extract is treated with  
2 ml of Ammonium molybdate 
solution and 2ml of concentrated 
nitric acid. 
presence of Yellow 
precipitate 
 
Present 
4 Test for Carbonate: 
2ml of the extract is treated with 
2ml of magnesium sulphate 
solution. 
Absence of white 
Precipitate 
Absent 
5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated Hcl. 
Absence of Rotten 
egg smelling 
Absent 
6 Test for Nitrate: 
1gm of the substance is heated 
with copper turnings and 
Absence of reddish 
brown gas. 
Absent 
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concentrated sulphuric acid and 
viewed the test tube vertically 
down. 
7a Test for Fluoride and oxalate 
2ml of the extract is added with 
2ml of dilute acetic acid and 2ml 
of calcium chloride solution and 
heated. 
Absence of white 
Precipitate 
Absent 
B 5 drops of clear solution is added 
with 2ml of diluted sulphuric 
acid and slightly warmed to this, 
1 ml of dilute potassium 
permanganate 
solution is added. 
KMNO4 solution 
Discolourisation not 
obtained 
Absent 
8 Test for Nitrite 
3 drops of the extract is placed 
on a filter paper. On that, 2 
drops of Acetic Acid and 2 drops 
of Benzidine solution is placed. 
Absence of 
yellowish red colour 
Absent 
9 Test for Borate 
2 pinches of the substance is 
made into paste by using 
Sulphuric acid and Alcohol 
(95%) and introduced into the 
blue flame. 
Presence of Green 
tinged flame 
Present 
II TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is added with 
2 ml of Potassium iodide 
solution. 
Absence of Yellow 
Precipitate 
Absent 
11a Test for Copper 
One pinch of substance is made 
into paste with concentrated 
Hydrochloric acid in a watch 
glass and introduced into the non 
luminous part of the flame. 
Absence of Bluish 
green coloured 
flame. 
Absent 
B 2ml of the extract is added with 
excess of Ammonia solution 
Absence of deep 
Blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. Sodium 
Hydroxide solution is added in 
drops to excess 
Absence of White 
Precipitate. 
Absent 
13a Test for Iron Absence of Blood Absent 
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To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
Solution is added. 
red colour 
B To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
solution and 2 ml of 
concentrated Nitric Acid is 
added. 
Blood red colour not 
obtained 
Absent 
14 Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in 
drops to excess. 
 
Absence of White 
precipitate. 
Absent 
15 Test for Calcium 
2 ml of the extract is added with 
2 ml of 4% Ammonium Oxalate 
solution. 
presence of White 
precipitate. 
Present 
16 Test for Magnesium 
2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
precipitate. 
Absent 
17 Test for Ammonium 
2 ml of extract few ml of 
Nessler’s Reagent and excess of 
Sodium Hydroxide solution are 
added. 
Absence of 
Reddish brown 
Precipitate 
Absent 
18 Test for Potassium 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 2 
ml of Cobal Nitrate in 30% 
glacial Acetic acid. 
Presence of Yellow 
precipitate 
 
Present 
19 Test for Sodium 
2 pinches of the substance is 
made into paste by using 
Hydrochloric acid and 
introduced into the blue flame. 
 
Absence of Yellow 
colour flame 
Absent 
20 Test for Mercury 
2 ml of the extract is treated with 
2 ml of Sodium Hydroxide 
solution. 
Absence of yellow 
Precipitate 
Absent 
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21 Test for Arsenic 
2 ml of extract is treated with 2 
ml of silver Nitrate solution. 
Absence of 
Yellow precipitate 
Absent 
22 Test for Starch 
2ml of extract is treated with 
weak iodine solution 
Absence of 
Blue colour 
Absent 
23 Test of reducing Sugar 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 minutes 
and added 10 drops of the 
extract and again boiled for 2 
minutes. The colour changes are 
noted. 
Absence of Green 
colour 
Absent 
24 Test of the alkaloids 
2ml of the extract is treated with 
2ml of potassium lodide 
solution. 
Absence of 
Red colour 
Absent 
25 Test of the proteins 
2ml of the extract is treated with 
2ml of 5% NaOH, mix well and 
add 2 drops of copper sulphate 
solution. 
Absence of 
Violet colour 
Absent 
 
RESULTS: 
The given sample Karpoora silasathu parpam contains,  
Calcium, Potassium, Borate, Phosphate. 
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BIO STATISTICAL ANALYSIS 
CLINICAL PROGNOSIS 
Treatment for Kalladaippu: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a hypothesis. 
 
S. 
No 
Signs&Symptoms Before Treatment After Treatment 
n% n% 
1. Flank pain 40(100) 5(12.5)** 
2. Nausea 6(15) 0(0)* 
3. Vomiting 2(5) 0(0)* 
4. Burning Micturition 18(45) 2(5)** 
5. Dysuria 2(5) 0(0)* 
6. Fever 4(10) 0(0)* 
7. Oliguria 12(30) 0(0)* 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in all symptoms. So there is significant 
reducing of symptoms among the patients for the treatment of Kalladaippu. Hence it is 
concluded that the treatment was effective and significant. 
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Treatment for Kalladaippu: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a hypothesis. 
 
DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
S. 
No 
Side Before Treatment After Treatment 
n% n% 
1. Rt – Kidney 11(27.5) 4(10)* 
2. Lt – Kidney 10(25) 3(7.5)* 
3. Bilateral 18(45) 9(22.5)* 
4. Ureteral 1(2.5) 0(0)*  
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in sides and ureteral there is a significant changes in 
distribution of calculi based on location. Hence it is concluded that the treatment was 
effective and significant. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “KARPOORA SILASATHU PARPAM” IN THE 
TREATMENT OF 
“KALLADAIPPU” (UROLITHIASIS) 
 
 INFORMED CONSENT FORM 
 
“I have read the foregoing information. I have had the opportunity to ask 
questions about it and any questions I have asked have been answered to my 
satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have the   
right to withdraw from the study at any time without in any way it affecting my further 
medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:    
Station:                                                                                  
Signature of participant:  
 
Signature of the Guide:    Signature of the Investigator:   
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CASE SHEET PROFORMA FOR KALLADAIPPU  
GOVT.SIDDHA MEDICAL COLLEGE&HOSPITAL, CHENNAI-106 
 POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
Duration: 2015-2017 
 
OP No / IP No  :    Occupation  : 
Ward No  :    Income  : 
Bed No  :    Nationality  : 
Name   :    Religion  : 
Age   :    D.O.A   : 
Sex   :    D.O.D   : 
Address  :    Diagnosis  : 
 
 
 
 
 
 
1. Complaints and duration  : 
 
 
 
 
2. History of present illness  : 
 
 
 
 
3. History of past illness  : 
 
 
 
 
4. Personal history   : 
 
 
5. Occupational history  : 
 
6. Menstrual history   : 
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7. Personal Habits   : Veg/non veg/smoker/Alcoholic/Tobacco 
chewer 
 
 
 
8. Family History   : 
 
 
GENERAL EXAMINATION  
Patient consciousness   : 
Body Built    : 
Nourishment    : 
Anemia    : 
Jaundice    : 
Cyanosis    : 
Clubbing    : 
JVP     : 
Tracheal deviation   : 
Pedal oedema    : 
Lymph adenopathy   : 
VITAL SIGNS 
Body Temp    : 
Pulse     : 
Respiratory rate   : 
Blood Pressure   : 
Weight    : 
SIDDHA ASPECT  
NILAM 
Kurinchi  : 
Mullai   : 
Marutham  : 
Neithal  : 
Palai   : 
 
CASE SHEET PRFORMA 
 
Karpoora silasathu parpam for Kalladaippu Page 149 
 
PARUVA KALAM 
Kaar   : 
Koothir  : 
Munpani  : 
Pinpani  : 
Elavenil  : 
Muduvenil  : 
YAAKKAI(Udal) 
Vaatham  : 
Pittham  : 
Kabam   : 
Kalappu  : 
GUNAM 
Satthuvam  : 
Rajotham  : 
Thamasam  
 
PULANGAL (SENSORY ORGANS) 
Mei –Sensation   : 
Vaai – Taste    : 
Kan – Vision     : 
Mooku - Smell    : 
Sevi – Hearing   : 
KANMENTHRIYAM/KANNMA VIDAYAM [MOTOR ORGANS] 
Kai- Dhaanam    : 
Kaal-Kamanam   : 
Vaai-Vasanam   : 
Eruvaai- Visarkkam   : 
Karuvaai-Aanantham   : 
UTHKAAYA ATHAKAAYAM 
Puyam[forearm]   : 
Sayam[arm]    : 
Kaal[leg]    : 
Paaatham[feet]   : 
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UYIR THATHUKKAL 
A.VATHAM 
 Piranan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
B.PITHAM 
Anar pitham   : 
Ranjaga pitham  : 
Saathaga pitham  : 
Pirrasaga pitham  : 
Alosaga pitham  : 
C.KABAM 
Avalambagam   : 
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam   : 
UDALTHAATHUKKAL 
Saaram   : 
Senner    : 
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai    : 
Sukkilam/Suronitham  : 
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ENVAGAI THERVUGAL 
1.Naa    : 
2.Niram   : 
3.Mozhi   : 
4.Vizhi   : 
5.Sparisam   : 
6.Malam   : 
7.Moothiram 
a)Neer Kuri  : 
 b)Nei Kuri  : 
8.Naadi   : 
MALAM 
 Niram    : 
 Edai    : 
 Irugal    : 
 Elagal    : 
MOOTHIRAM 
 1.Neerkuri 
  Niram   : 
  Manam  : 
  Edai   : 
  Nurai   : 
  Enjal   : 
 2.Neikuri 
MODERN ASPECT 
  Systemic Examination  
 Inspection   : 
 Palpation   : 
                    Renal angle                     : 
                    Tenderness                      : Present/Absent  
                    Radiation                         :      
 Percussion    : 
 Auscultation    : 
  Others Systems  
 Cardio Vascular System : 
 Respiratory system  : 
 Central nervous system :  
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CLINICAL SIGN AND SYMPTOMS OF KALLADAIPPU 
 
 
S.N
o 
 
Symptoms 
 
Before 
Treatmen
t 
After Treatment 
7
th
 
day 
14
th
 
day 
21
st
 
day 
28
th
 
day 
35
th
 
day 
42nd 
day 
49th 
day 
1 Pain 
 Site 
 Radiation 
 Character 
        
2 Nausea         
3 Vomiting         
4 Burning Micturition         
5 Dysuria         
6 Oliguria         
7 Haematuria         
8 Retention         
9 Fever         
10 Frequency of 
Micturition 
        
 
  INVESTIGATION 
      1. BLOOD 
  TC 
  DC 
  ESR 
  Bleeding time 
  Clotting time 
  Blood sugar 
  Blood urea 
  Serum cholesterol 
Serum calcium  
  VDRL 
 
      2. URINE 
    Colour 
  Turbidity 
  Albumin 
  Sugar 
  Deposits 
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 Epithelial cells 
 RBC’s 
 Pus cells 
Casts 
Specific gravity 
Urine culture and sensitivity 
       
      3. USG Abdomen and Pelvis 
 
      4. X-Ray KUB 
  
CASE SUMMARY 
 
 
 
DIAGNOSIS 
 KALLADAIPPU (UROLITHIASIS) 
 
 
 
TRIAL DRUG: KARPOORA SILASATHU PARPAM 
 
Dose: 130 mg 
Anubanam : Ilaneer 
Duration of Treatment: 48 days 
Pathiam (Do’s and Don’ts) 
DO’S: 
 
1) Drink 4-5 litres of water per day. 
2) Dring tender coconut, barley water, lemon juice, raddish juice. 
3) The following vegetables can be taken in the diet 
Raddish  
Lady’s finger 
Plantain pith 
Mint leaves 
Bottle guard 
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DONT’S: 
 
1) Avoid cabbage, cauliflower, tomato seeds, mushroom. 
2) Avoid milk and its products. 
3) Avoid chicken, fish and other sea foods 
4) Avoid drinking fluoride containing water. 
 
Prognosis  
 
 
 
 
 
 
Medical Officer Signature:       HOD 
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